https://curecurrent.com/trials/the-lifestyle-education-about-prediabetes-leap-study-1https://curecurrent.com/trials/trial-against-intractable-type-2-diabetes-captain-t2d-2https://curecurrent.com/trials/genetic-studies-of-insulin-and-diabetes-3https://curecurrent.com/trials/wake-forest-alzheimer-s-disease-clinical-core-4https://curecurrent.com/trials/effects-of-meal-macronutrients-on-postprandial-lipids-5https://curecurrent.com/trials/inspiratory-muscle-strength-training-in-adults-with-type-1-diabetes-6https://curecurrent.com/trials/efficacy-and-safety-of-ribupatide-administered-once-weekly-in-participants-living-with-obesity-or-overweight-and-diabete-7https://curecurrent.com/trials/efficacy-and-safety-of-ribupatide-in-participants-living-with-obesity-or-overweight-with-weight-related-comorbidities-wh-8https://curecurrent.com/trials/manage-dm-novel-nurse-case-management-to-improve-diabetes-outcomes-in-formerly-incarcerated-black-men-9https://curecurrent.com/trials/a-study-of-enicepatide-ct-388-in-participants-who-are-overweight-or-obese-with-type-2-diabetes-mellitus-10https://curecurrent.com/trials/study-of-gs-4571-in-healthy-participants-nondiabetic-obese-participants-and-nonobese-participants-with-type-2-diabetes-m-11https://curecurrent.com/trials/cbti-for-the-treatment-of-insomnia-in-type-1-diabetes-12https://curecurrent.com/trials/advancing-diabetes-management-for-people-with-physical-disabilities-optimally-through-primary-care-based-telehealth-addo-13https://curecurrent.com/trials/diabetes-prevention-program-with-or-without-hunger-training-in-helping-to-lower-breast-cancer-risk-in-obese-participants-14https://curecurrent.com/trials/imaging-in-semaglutide-study-15https://curecurrent.com/trials/evaluation-of-arts-based-storytelling-program-in-adolescents-with-diabetes-16https://curecurrent.com/trials/efficacy-and-safety-of-ribupatide-administered-once-weekly-compared-with-semaglutide-and-placebo-in-participants-living-17https://curecurrent.com/trials/evaluation-of-the-clinical-spectrum-of-diabetes-and-obesity-in-youth-and-adults-18https://curecurrent.com/trials/a-natural-history-study-of-metabolic-sizing-in-health-and-disease-19https://curecurrent.com/trials/smart-2d-study-of-montelukast-s-effects-on-renal-and-cardiovascular-health-in-adolescents-and-young-adults-with-type-2-d-20https://curecurrent.com/trials/the-reset-system-pivotal-clinical-trial-protocol-revision-h-21https://curecurrent.com/trials/insul-in-this-together-leveraging-family-support-and-diabetes-technology-for-adolescents-living-with-type-1-diabetes-22https://curecurrent.com/trials/extension-trial-to-evaluate-the-long-term-efficacy-safety-and-tolerability-of-maridebart-cafraglutide-maritime-2-extensi-23https://curecurrent.com/trials/monounsaturated-fatty-acid-supplementation-for-overweight-and-obese-individuals-with-prediabetes-24https://curecurrent.com/trials/clinical-application-of-stem-cell-educator-therapy-in-type-1-diabetes-25https://curecurrent.com/trials/balance4mobility-effects-of-walkasins-use-in-individuals-with-peripheral-neuropathy-and-balance-problems-26https://curecurrent.com/trials/advancing-precision-nutrition-wearable-technology-for-noninvasive-insulin-monitoring-27https://curecurrent.com/trials/enhancing-shared-decision-making-to-guide-care-for-people-with-dementia-and-diabetes-28https://curecurrent.com/trials/glycemic-and-weight-loss-effects-of-glp-1r-agonist-therapy-in-subjects-with-spinal-cord-injury-and-type-2-diabetes-29https://curecurrent.com/trials/mediterranean-diet-and-blood-sugar-study-30https://curecurrent.com/trials/a-12-week-pilot-nutrition-intervention-for-children-with-new-diagnosis-of-stage-3-type-1-diabetes-t1d-31https://curecurrent.com/trials/integrating-new-skills-into-diabetes-education-with-cgm-32https://curecurrent.com/trials/the-genomic-medicine-at-va-study-33https://curecurrent.com/trials/molecular-and-clinical-profile-of-diabetes-mellitus-and-its-complications-34https://curecurrent.com/trials/envision-cf-multicenter-study-of-glucose-tolerance-in-cystic-fibrosis-35https://curecurrent.com/trials/people-with-chc-who-achieved-a-sustained-virological-response-following-therapy-with-direct-acting-antiviral-agents-36https://curecurrent.com/trials/developing-the-family-map-looking-at-communal-coping-37https://curecurrent.com/trials/leveraging-artificial-intelligence-to-prevent-vision-loss-from-diabetes-38https://curecurrent.com/trials/lifestyle-interventions-for-expectant-mothers-life-moms-phoenix-phoenix-39https://curecurrent.com/trials/national-eye-institute-biorepository-for-retinal-diseases-40https://curecurrent.com/trials/study-of-inv-102-ophthalmic-solution-in-adults-with-diabetic-macular-edema-associated-with-non-proliferative-diabetic-re-41https://curecurrent.com/trials/efficacy-of-using-mobile-health-applications-for-health-42https://curecurrent.com/trials/efficacy-of-mhealth-apps-for-health-in-a-low-income-type-ii-diabetic-hispanic-population-43https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-orally-administered-vx-01-44https://curecurrent.com/trials/finding-immune-nascent-type-1-diabetes-45https://curecurrent.com/trials/a-study-to-evaluate-safety-tolerability-and-pharmacokinetics-of-orally-administered-tix100-in-healthy-subjects-46https://curecurrent.com/trials/compassionate-use-of-metreleptin-in-previously-treated-people-with-partial-lipodystrophy-47https://curecurrent.com/trials/vitamin-e-pharmacokinetics-and-biomarkers-in-normal-and-obese-women-48https://curecurrent.com/trials/a-research-study-comparing-how-well-different-doses-of-the-medicine-nnc0487-0111-lower-blood-sugar-in-people-with-type-2-49https://curecurrent.com/trials/investigating-metabolic-and-psychological-adaptations-in-a-clinical-trial-50https://curecurrent.com/trials/a-research-study-investigating-how-adults-with-overweight-or-obesity-with-or-without-type-2-diabetes-tolerate-switching-51https://curecurrent.com/trials/new-heart-imaging-techniques-to-evaluate-possible-heart-disease-52https://curecurrent.com/trials/reducing-weight-and-diabetes-risk-in-an-underserved-population-stride-53https://curecurrent.com/trials/synchronize-start-a-study-to-test-whether-survodutide-helps-people-living-with-overweight-or-obesity-who-do-not-have-dia-54https://curecurrent.com/trials/cross-sectional-and-longitudinal-studies-of-pre-diabetes-in-the-pima-indians-55https://curecurrent.com/trials/dietary-behavior-intervention-in-african-americans-at-risk-for-cardiovascular-disease-56https://curecurrent.com/trials/hydration-intervention-to-decrease-side-effects-associated-with-glp-1-ra-therapy-57https://curecurrent.com/trials/total-contact-soft-cast-in-diabetic-foot-ulcers-58https://curecurrent.com/trials/a-study-of-fresh-produce-and-ai-enabled-nutrition-support-in-adults-with-diabetes-in-rural-appalachia-59https://curecurrent.com/trials/training-induced-muscle-adipose-ev-communication-60https://curecurrent.com/trials/effect-of-percutaneous-electrical-nerve-field-stimulation-on-symptom-control-nervous-system-activity-in-patients-w-diabe-61https://curecurrent.com/trials/implementation-program-to-improve-screening-and-management-for-ckd-in-diabetes-iris-ckd-program-2-62https://curecurrent.com/trials/expanding-technology-enabled-nurse-delivered-chronic-disease-care-63https://curecurrent.com/trials/a-prospective-multicenter-randomized-controlled-trial-with-a-non-randomized-sentinel-cohort-evaluating-the-efficacy-of-b-64https://curecurrent.com/trials/autologous-cd6-car-treg-cells-for-patients-with-stage-3-type-1-diabetes-65https://curecurrent.com/trials/watchwell-simple-and-practical-strategies-to-reduce-the-negative-health-impact-of-sedentary-screen-time-66https://curecurrent.com/trials/a-clinical-trial-of-mk-8748-compared-to-aflibercept-in-participants-with-diabetic-macular-edema-mk-8748-004-67https://curecurrent.com/trials/remote-temperature-and-visual-monitoring-to-help-manage-diabetic-foot-ulcers-68https://curecurrent.com/trials/efficacy-of-human-placental-membrane-products-and-standard-of-care-in-the-management-of-nonhealing-diabetic-foot-ulcers-69https://curecurrent.com/trials/technology-supported-treatment-of-sleep-apnea-in-prediabetes-70https://curecurrent.com/trials/a-clinical-trial-of-mk-8748-compared-to-aflibercept-in-participants-with-diabetic-macular-edema-mk-8748-005-71https://curecurrent.com/trials/implementation-program-to-improve-screening-and-management-for-ckd-in-diabetes-program-1-iris-ckd-72https://curecurrent.com/trials/metabolic-impact-of-pancreatic-duct-decompression-73https://curecurrent.com/trials/a-real-world-data-collection-of-human-amniotic-membrane-s-on-diabetic-foot-ulcers-venous-leg-ulcers-pressure-ulcers-and-74https://curecurrent.com/trials/a-study-to-compare-different-doses-of-ro7795081-with-placebo-or-semaglutide-in-people-with-type-2-diabetes-75https://curecurrent.com/trials/family-genetics-health-education-and-healthy-behaviors-76https://curecurrent.com/trials/health-electronic-assessment-of-risks-and-trends-using-biometric-equipment-and-technology-77https://curecurrent.com/trials/scaling-telehealth-models-to-improve-co-morbid-diabetes-and-hypertension-phase-ii-78https://curecurrent.com/trials/role-of-alpha-to-beta-cell-communication-to-adapt-insulin-secretion-to-insulin-resistance-79https://curecurrent.com/trials/a-study-of-orforglipron-ly3502970-in-participants-with-type-2-diabetes-and-inadequate-glycemic-control-with-insulin-glar-80https://curecurrent.com/trials/a-study-to-test-whether-bi-764524-helps-people-with-an-eye-condition-called-diabetic-retinopathy-81https://curecurrent.com/trials/motivation-psychology-based-smart-engagement-system-82https://curecurrent.com/trials/amaze-2-a-research-study-investigating-how-well-the-medicine-nnc0487-0111-helps-people-with-excess-body-weight-and-type-83https://curecurrent.com/trials/research-study-on-how-people-with-type-2-diabetes-tolerate-switching-from-semaglutide-to-cagrisema-84https://curecurrent.com/trials/a-study-of-clazakizumab-ly5724886-in-adults-with-elevated-hscrp-and-at-increased-risk-for-cardiovascular-event-85https://curecurrent.com/trials/the-resplash-study-86https://curecurrent.com/trials/precision-nutrition-for-obesity-and-prediabetes-prevention-in-under-supported-communities-87https://curecurrent.com/trials/long-term-comparative-effectiveness-of-once-weekly-semaglutide-versus-standard-of-care-in-a-real-world-adult-us-populati-88https://curecurrent.com/trials/a-research-study-to-see-how-much-cagrisema-lowers-blood-sugar-and-body-weight-compared-to-placebo-in-people-with-type-2-89https://curecurrent.com/trials/a-study-to-test-whether-survodutide-helps-people-with-type-2-diabetes-control-their-blood-sugar-90https://curecurrent.com/trials/easi-protkt-a-study-to-test-vicadrostat-bi-690517-taken-together-with-empagliflozin-in-people-with-type-2-diabetes-high-91https://curecurrent.com/trials/glycemic-effect-of-diazoxide-in-nafld-92https://curecurrent.com/trials/a-research-study-to-look-at-how-two-different-doses-of-cagrisema-and-one-dose-of-semaglutide-help-people-living-with-obe-93https://curecurrent.com/trials/glucose-understanding-integrated-digital-health-and-engagement-guide-study-94https://curecurrent.com/trials/study-of-olatorepatide-in-adult-participants-living-with-overweight-or-obesity-without-diabetes-95https://curecurrent.com/trials/changing-health-through-food-support-for-diabetes-96https://curecurrent.com/trials/family-centered-weight-loss-for-black-adults-fam-wel-b-ing-97https://curecurrent.com/trials/a-study-to-investigate-weight-management-with-ly3841136-and-tirzepatide-ly3298176-alone-or-in-combination-in-adult-parti-98https://curecurrent.com/trials/nt-probnp-based-heart-failure-screening-and-prevention-trial-in-patients-with-type-2-diabetes-strong-dm-study-99https://curecurrent.com/trials/continuous-glucose-monitoring-in-the-intensive-care-unit-100https://curecurrent.com/trials/teplizumab-in-pediatric-stage-2-type-1-diabetes-101https://curecurrent.com/trials/a-study-of-patas-using-single-ascending-doses-in-healthy-volunteers-and-multiple-ascending-doses-in-diabetic-subjects-102https://curecurrent.com/trials/effects-of-hourly-stair-climbing-exercise-snacks-on-metabolic-and-vascular-health-in-adults-with-prediabetes-103https://curecurrent.com/trials/intermittent-fasting-for-the-treatment-of-type-2-diabetes-mellitus-104https://curecurrent.com/trials/a-study-to-assess-the-efficacy-safety-and-tolerability-of-at673-co-administered-with-semaglutide-in-adult-participants-w-105https://curecurrent.com/trials/a-randomized-controlled-trial-of-diabetes-screening-immediately-postpartum-dip-and-follow-up-pp-care-106https://curecurrent.com/trials/calcium-and-vasopressin-following-injury-early-resuscitation-cavalier-trial-107https://curecurrent.com/trials/a-randomized-comparison-of-stage-based-care-versus-risk-factor-based-care-for-prevention-of-cardiovascular-events-108https://curecurrent.com/trials/postpartum-semaglutide-to-reduce-cardiometabolic-risk-after-gestational-diabetes-mellitus-109https://curecurrent.com/trials/pleasure-pleasing-lovers-efficacy-arousal-satisfaction-and-uptake-research-on-eroxon-110https://curecurrent.com/trials/corticosteroid-for-diabetic-macular-edema-dme-study-111https://curecurrent.com/trials/diabetes-and-heart-disease-risk-in-blacks-112https://curecurrent.com/trials/obstructive-sleep-apnea-among-somali-americans-113https://curecurrent.com/trials/liver-x-receptor-lxr-as-a-novel-therapeutic-target-in-diabetic-retinopathy-dr-114https://curecurrent.com/trials/family-investigation-of-nephropathy-and-diabetes-f-i-n-d-115https://curecurrent.com/trials/healthy-aging-in-neighborhoods-of-diversity-across-the-life-span-handls-116https://curecurrent.com/trials/mechanisms-of-diabetic-kidney-disease-in-american-indians-117https://curecurrent.com/trials/pivotal-trial-for-an-automated-ai-based-system-for-detection-of-diabetic-retinopathy-118https://curecurrent.com/trials/study-of-alv-100-to-assess-safety-tolerability-and-pk-pd-in-overweight-obese-participants-with-or-without-t2d-119https://curecurrent.com/trials/early-tracking-of-childhood-health-determinants-etched-study-120https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-berobenatide-pf-08653944-in-people-with-overweight-or-obesity-121https://curecurrent.com/trials/using-continuous-glucose-monitoring-to-quantify-the-effects-of-nourish-s-culturally-modified-meals-on-asian-americans-wi-122https://curecurrent.com/trials/effect-of-retatrutide-compared-with-semaglutide-in-adult-participants-with-type-2-diabetes-and-inadequate-glycemic-contr-123https://curecurrent.com/trials/modality-choice-before-and-after-failure-for-the-treatment-of-painful-diabetic-neuropathy-124https://curecurrent.com/trials/healthy-living-anson-study-125https://curecurrent.com/trials/a-study-of-orforglipron-in-participants-with-overweight-at-risk-of-development-of-obesity-related-complications-or-progr-126https://curecurrent.com/trials/a-study-of-orforglipron-ly3502970-compared-with-dulaglutide-in-pediatric-participants-with-type-2-diabetes-127https://curecurrent.com/trials/stride-supporting-early-diabetes-self-management-for-parents-128https://curecurrent.com/trials/pre-surgical-tirzepatide-assisted-weight-loss-in-overweight-and-obese-men-with-intermediate-risk-prostate-cancer-a-pilot-129https://curecurrent.com/trials/a-research-study-to-see-how-a-weekly-insulin-insulin-icodec-helps-in-reducing-the-blood-sugar-compared-to-daily-insulin-130https://curecurrent.com/trials/safety-and-drug-concentrations-of-regn20934-in-adults-with-overweight-or-obesity-131https://curecurrent.com/trials/treatment-of-type-i-diabetes-by-islet-transplantation-into-the-gastric-submucosa-study-protocol-132https://curecurrent.com/trials/a-study-to-evaluate-effect-of-azd6234-as-an-adjunct-to-incretin-based-therapies-in-adult-participants-with-obesity-or-ov-133https://curecurrent.com/trials/assessing-the-value-of-avocados-on-glycemic-control-in-type-2-diabetes-134https://curecurrent.com/trials/starting-technology-in-at-risk-type-1-diabetes-study-135https://curecurrent.com/trials/food-is-medicine-in-pediatric-patients-with-diabetes-136https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-pf-08653944-in-people-with-obesity-or-overweight-and-type-2-diabetes-t2d-137https://curecurrent.com/trials/patient-centered-multi-agent-decision-support-system-pcm-dss-for-healthcare-providers-138https://curecurrent.com/trials/lifestyle-change-implementation-research-network-at-prc-at-umass-chan-139https://curecurrent.com/trials/promoting-preconception-care-and-diabetes-self-management-among-reproductive-aged-women-with-diabetes-140https://curecurrent.com/trials/hybrid-closed-loop-therapy-and-verapamil-for-beta-cell-preservation-in-new-onset-type-1-diabetes-clver-extension-study-141https://curecurrent.com/trials/the-effect-of-retatrutide-once-weekly-on-cardiovascular-outcomes-and-kidney-outcomes-in-adults-living-with-obesity-trium-142https://curecurrent.com/trials/a-research-study-to-see-if-kidney-damage-in-people-with-chronic-kidney-disease-and-type-2-diabetes-living-with-overweigh-143https://curecurrent.com/trials/surabgene-lomparvovec-administered-in-the-suprachoroidal-space-in-adult-participants-with-diabetic-retinopathy-without-c-144https://curecurrent.com/trials/whole-food-fibers-for-support-of-key-gut-bacteria-for-human-health-145https://curecurrent.com/trials/implementation-of-a-peer-leader-facilitated-dyadic-intervention-146https://curecurrent.com/trials/supporting-transitions-to-primary-care-among-under-resourced-postpartum-women-step-up-147https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-azd6234-in-participants-living-with-overweight-or-obesity-with-type-2-diabetes-who-a-148https://curecurrent.com/trials/continuous-glucose-monitoring-in-patients-undergoing-cardiopulmonary-bypass-149https://curecurrent.com/trials/an-observational-study-to-learn-more-about-how-safe-finerenone-is-and-how-well-it-works-in-people-with-chronic-kidney-di-150https://curecurrent.com/trials/continued-access-to-the-endogenex-system-for-participants-in-the-recet-pivotal-study-151https://curecurrent.com/trials/the-effect-of-providing-genetic-risk-information-on-lifestyle-behaviors-in-african-americans-152https://curecurrent.com/trials/i-tracking-neurodegeneration-in-early-wolfram-syndrome-153https://curecurrent.com/trials/access-2-ai-for-pediatric-diabetic-eye-exams-study-2-154https://curecurrent.com/trials/app-based-certified-diabetes-education-therapy-ab-cde-155https://curecurrent.com/trials/non-invasive-testing-to-evaluate-wound-healing-in-diabetes-156https://curecurrent.com/trials/dietary-insights-and-nutritional-education-in-adults-on-glp-1-therapy-157https://curecurrent.com/trials/assessing-effectiveness-of-a-diabetes-navigator-in-increasing-progression-of-advanced-diabetes-technologies-158https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-in-participants-with-type-1-diabetes-mellitus-and-overweight-or-obesity-159https://curecurrent.com/trials/bringing-the-diabetes-prevention-program-to-geriatric-populations-160https://curecurrent.com/trials/video-based-patient-education-intervention-for-diabetic-eye-screening-in-latinx-communities-161https://curecurrent.com/trials/urinary-vitamin-c-loss-in-diabetic-subjects-162https://curecurrent.com/trials/a-study-of-baricitinib-ly3009104-for-the-delay-of-stage-3-type-1-diabetes-in-at-risk-children-and-adults-163https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-immunomodulation-with-a-monoclonal-antibody-against-cd40l-in-combination-with-transp-164https://curecurrent.com/trials/a-study-of-eloralintide-ly3841136-in-participants-with-obesity-or-overweight-without-type-2-diabetes-165https://curecurrent.com/trials/returning-to-normoglycemia-with-targeted-use-of-real-time-cgm-data-and-nutrition-focused-lifestyle-changes-166https://curecurrent.com/trials/nutrition-optimization-and-community-upliftment-for-postpartum-recovery-167https://curecurrent.com/trials/continuous-glucose-monitoring-and-behavioral-change-intervention-for-people-with-type-2-diabetes-and-diabetes-distress-168https://curecurrent.com/trials/a-study-of-baricitinib-ly3009104-to-preserve-beta-cell-function-in-children-and-adults-newly-diagnosed-with-type-1-diabe-169https://curecurrent.com/trials/pre-diabetes-in-subject-with-impaired-fasting-glucose-ifg-and-impaired-glucose-tolerance-igt-170https://curecurrent.com/trials/a-study-of-eloralintide-ly3841136-in-participants-with-persistent-obesity-who-are-treated-with-a-weekly-incretin-171https://curecurrent.com/trials/a-study-to-evaluate-effect-of-azd6234-in-adult-participants-with-type-2-diabetes-mellitus-and-obesity-or-overweight-172https://curecurrent.com/trials/investigating-the-use-of-quercetin-on-glucose-absorption-in-obesity-and-obesity-with-type-2-diabetes-173https://curecurrent.com/trials/a-u-s-pilot-human-investigation-of-radiofrequency-vapor-ablation-system-to-evaluate-safety-tolerability-and-effectivenes-174https://curecurrent.com/trials/compassionate-use-of-metreleptin-in-previously-treated-people-with-generalized-lipodystrophy-175https://curecurrent.com/trials/pioglitazone-on-heart-failure-in-type-2-diabetes-mellitus-participants-176https://curecurrent.com/trials/prospective-studies-of-the-natural-history-of-diabetes-mellitus-and-its-complications-in-the-gila-river-indian-community-177https://curecurrent.com/trials/a-study-of-eloralintide-ly3841136-in-participants-with-obesity-or-overweight-and-type-2-diabetes-178https://curecurrent.com/trials/evaluating-several-cellular-acellular-and-matrix-like-products-camps-and-standard-of-care-versus-standard-of-care-alone-179https://curecurrent.com/trials/food-delivery-remote-monitoring-and-coaching-enhanced-education-for-optimized-diabetes-management-freedom-180https://curecurrent.com/trials/a-study-to-investigate-weight-management-with-macupatide-and-eloralintide-alone-or-in-combination-in-adult-participants-181https://curecurrent.com/trials/weight-loss-clinical-decision-support-182https://curecurrent.com/trials/comparative-effectiveness-of-oral-semaglutide-vs-sitagliptin-among-individuals-with-heart-failure-with-preserved-ejectio-183https://curecurrent.com/trials/phenotyping-genetic-risk-for-type-2-diabetes-184https://curecurrent.com/trials/sglt2-inhibitor-therapy-in-cystic-fibrosis-related-diabetes-185https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-safety-and-tolerability-of-asc30-tablets-in-participants-with-type-2-diabetes-mellitus-186https://curecurrent.com/trials/lifestyle-patterns-and-glycemic-control-187https://curecurrent.com/trials/glucagon-like-peptide-1-metabolism-and-acute-neprilysin-inhibition-188https://curecurrent.com/trials/combined-dose-finding-and-cv-outcomes-study-with-csl300-clazakizumab-in-adult-subjects-with-eskd-undergoing-dialysis-pos-189https://curecurrent.com/trials/a-research-study-comparing-how-well-different-doses-of-the-medicine-nn0519-0130-lower-blood-sugar-in-people-with-type-2-190https://curecurrent.com/trials/meals-for-me-drop-shipment-versus-personally-delivered-meals-for-diabetes-management-191https://curecurrent.com/trials/glucose-metabolism-in-sickle-cell-disease-192https://curecurrent.com/trials/cadisegliatin-as-adjunctive-therapy-to-insulin-in-participants-with-type-1-diabetes-who-are-using-hybrid-closed-loop-hcl-193https://curecurrent.com/trials/a-non-interventional-pilot-study-to-explore-the-role-of-gut-flora-in-disease-194https://curecurrent.com/trials/improving-the-collaborative-health-of-adult-dyads-195https://curecurrent.com/trials/evaluate-safety-and-effectiveness-of-mbx-102-in-type-2-diabetes-patients-with-poor-glycemic-control-on-metformin-196https://curecurrent.com/trials/study-of-au-007-a-monoclonal-antibody-that-binds-to-il-2-and-inhibits-il-2r-binding-in-patients-with-unresectable-locall-197https://curecurrent.com/trials/evaluation-of-nutritional-interventions-to-limit-gestational-weight-gain-in-women-with-class-iii-obesity-bmi-40-198https://curecurrent.com/trials/comparative-study-of-tirzepatide-versus-dulaglutide-surpass-cvot-or-semaglutide-on-major-cardiovascular-events-in-partic-199https://curecurrent.com/trials/18f-fdg-pet-ct-for-diagnosis-of-diabetic-foot-osteomyelitis-200https://curecurrent.com/trials/type-1-diabetes-extension-study-201https://curecurrent.com/trials/georgia-ceal-restores-family-diabetes-study-202https://curecurrent.com/trials/sleep-loss-and-circadian-misalignment-mechanisms-of-insulin-resistance-203https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-tolerability-and-pharmacokinetics-of-mbx-2982-administered-daily-for-4-weeks-as-mo-204https://curecurrent.com/trials/bionic-pancreas-in-cfrd-205https://curecurrent.com/trials/multimodal-glucose-prediction-in-type-2-diabetes-206https://curecurrent.com/trials/cgm-dynamic-index-for-predicting-prediabetes-in-cystic-fibrosis-207https://curecurrent.com/trials/evaluating-glial-acetate-metabolism-as-a-biomarker-of-hypoglycemic-counterregulation-208https://curecurrent.com/trials/a-nutritional-intervention-in-police-officers-209https://curecurrent.com/trials/feasibility-implementation-of-a-plant-based-weight-loss-program-in-an-office-based-setting-210https://curecurrent.com/trials/youth-onset-type-2-diabetes-and-heart-disease-the-young-at-heart-prospective-cohort-study-211https://curecurrent.com/trials/promoting-successful-weight-loss-in-primary-care-in-louisiana-using-information-technology-212https://curecurrent.com/trials/evaluation-of-maridebart-cafraglutide-in-adult-participants-without-type-2-diabetes-mellitus-who-have-obesity-or-are-ove-213https://curecurrent.com/trials/plant-based-online-weight-loss-through-education-and-resources-program-and-study-214https://curecurrent.com/trials/long-term-follow-up-study-of-participants-exposed-to-renal-autologous-cell-therapy-frozen-product-215https://curecurrent.com/trials/diabetes-prevention-ai-enhancing-prevention-strategies-using-personalized-nutrition-and-fitness-coaching-for-the-next-ge-216https://curecurrent.com/trials/personalized-environment-and-genes-study-217https://curecurrent.com/trials/home-food-delivery-for-diabetes-management-in-patients-of-rural-clinics-218https://curecurrent.com/trials/cooking-health-oriented-meals-to-prevent-dementia-and-diabetes-219https://curecurrent.com/trials/a-study-to-investigate-the-relative-bioavailability-and-safety-of-different-oral-formulations-of-elecoglipron-in-healthy-220https://curecurrent.com/trials/clinical-applications-of-advanced-ophthalmic-imaging-221https://curecurrent.com/trials/a-randomized-parallel-clinical-trial-of-aidanet-an-automated-insulin-delivery-algorithm-in-fully-closed-loop-vs-hybrid-c-222https://curecurrent.com/trials/a-study-to-evaluate-aln-4324-on-insulin-sensitivity-in-adults-with-type-2-diabetes-mellitus-223https://curecurrent.com/trials/strategies-to-enhance-new-cgm-use-in-early-childhood-sence-224https://curecurrent.com/trials/a-study-of-once-daily-oral-asc30-to-evaluate-the-efficacy-and-safety-in-adult-participants-with-obesity-or-overweight-wi-225https://curecurrent.com/trials/a-study-to-evaluate-aln-4324-in-overweight-to-obese-healthy-volunteers-and-in-overweight-to-obese-patients-with-t2dm-226https://curecurrent.com/trials/longitudinal-natural-history-study-of-retinal-function-in-eyes-of-patients-with-diabetes-227https://curecurrent.com/trials/transdiagnostic-intervention-to-reduce-internalized-health-related-stigma-228https://curecurrent.com/trials/taste-bud-derived-stem-cells-in-humans-229https://curecurrent.com/trials/effects-of-use-of-a-connected-pillbox-on-medication-adherence-230https://curecurrent.com/trials/glucose-and-blood-pressure-during-pregnancy-231https://curecurrent.com/trials/home-video-based-telemedicine-to-reduce-hypoglycemia-fear-in-parents-of-young-children-232https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-nt-0796-in-participants-with-obesity-with-or-without-type-2-diabetes-mellitus-233https://curecurrent.com/trials/helping-adults-with-type-2-diabetes-use-their-health-data-for-healthy-diabetes-self-management-234https://curecurrent.com/trials/a-study-of-orforglipron-ly3502970-compared-with-semaglutide-in-participants-with-type-2-diabetes-inadequately-controlled-235https://curecurrent.com/trials/link-it-leveraging-videos-and-community-health-workers-to-improve-diabetes-outcomes-236https://curecurrent.com/trials/geko-cross-therapy-registry-wound-237https://curecurrent.com/trials/caregiving-networks-across-disease-context-and-the-life-course-238https://curecurrent.com/trials/pharmacist-led-continuous-glucose-monitoring-239https://curecurrent.com/trials/a-clinical-trial-of-mk-1403-in-participants-with-type-2-diabetes-mellitus-mk-1403-006-240https://curecurrent.com/trials/a-study-of-cx11-tablets-in-patients-with-type-2-diabetes-mellitus-241https://curecurrent.com/trials/metabolic-modulation-to-enhance-insulin-sensitivity-and-mitochondrial-function-in-type-1-diabetes-metmod-t1d-242https://curecurrent.com/trials/spyral-affirm-global-study-of-rdn-with-the-symplicity-spyral-rdn-system-in-subjects-with-uncontrolled-htn-243https://curecurrent.com/trials/time-in-glucose-hospital-target-244https://curecurrent.com/trials/a-study-of-ly3457263-compared-with-placebo-in-participants-with-type-2-diabetes-on-a-stable-dose-of-semaglutide-or-tirze-245https://curecurrent.com/trials/pregnancy-and-postpartum-breastfeeding-support-for-patients-with-gestational-diabetes-246https://curecurrent.com/trials/transverse-tibial-bone-transport-ttt-in-the-management-of-chronic-diabetic-lower-extremity-wounds-247https://curecurrent.com/trials/matrion-decellularized-placental-membrane-versus-conventional-wound-management-in-subjects-with-diabetic-foot-ulcers-248https://curecurrent.com/trials/single-site-pilot-study-evaluating-the-effect-of-qls-111-ophthalmic-solution-on-posterior-perfusion-and-vessel-dilation-249https://curecurrent.com/trials/enhancing-mental-and-physical-health-of-women-veterans-250https://curecurrent.com/trials/a-study-to-investigate-efficacy-and-safety-of-teplizumab-compared-with-placebo-in-participants-1-to-25-years-of-age-with-251https://curecurrent.com/trials/decreasing-cardiovascular-risk-for-patients-with-diabetes-252https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-effects-of-enicepatide-ro7795068-in-participants-with-obesity-or-overweight-without-typ-253https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-effects-of-enicepatide-ro7795068-in-participants-with-obesity-or-overweight-and-type-2-254https://curecurrent.com/trials/addressing-diabetes-by-elevating-access-to-nutrition-255https://curecurrent.com/trials/empower-study-strengths-based-behavioral-intervention-for-youth-with-type-1-diabetes-256https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-and-pharmacokinetics-of-ro7663498-following-intravitreal-administration-i-257https://curecurrent.com/trials/digital-behavioral-therapy-to-reduce-diabetes-and-liver-disease-risk-258https://curecurrent.com/trials/eating-disorder-prevention-program-for-women-with-t1d-259https://curecurrent.com/trials/a-research-study-comparing-how-well-different-doses-of-the-medicine-ubt251-lower-blood-sugar-in-people-with-type-2-diabe-260https://curecurrent.com/trials/real-time-engagement-for-learning-to-effectively-control-type-2-diabetes-261https://curecurrent.com/trials/testing-an-integrated-care-model-trial-262https://curecurrent.com/trials/a-study-of-maridebart-cafraglutide-in-adult-participants-with-type-2-diabetes-mellitus-t2dm-263https://curecurrent.com/trials/sleep-for-health-study-on-the-effects-of-cognitive-behavioral-therapy-for-insomnia-on-diabetes-risk-264https://curecurrent.com/trials/cnp-103-in-adolescent-and-adult-subjects-ages-12-35-with-recently-diagnosed-within-6-months-stage-3-type-1-diabetes-t1d-265https://curecurrent.com/trials/starvation-in-the-treatment-of-diabetic-ketoacidosis-266https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-in-participants-with-overweight-or-obesity-and-chronic-kidney-disease-with-or-without-t-267https://curecurrent.com/trials/a-study-of-aleniglipron-in-adults-with-obesity-or-overweight-and-type-2-diabetes-mellitus-accomplish-2-268https://curecurrent.com/trials/study-to-assess-the-effects-of-aln-ang3-in-adult-participants-with-diabetic-kidney-disease-269https://curecurrent.com/trials/a-research-study-comparing-how-well-different-doses-of-the-medicine-nnc0662-0419-lower-blood-sugar-in-people-with-type-2-270https://curecurrent.com/trials/genetics-of-obesity-diabetes-and-heart-disease-in-african-diaspora-populations-271https://curecurrent.com/trials/a-research-study-to-investigate-the-effects-of-cagrisema-compared-to-placebo-in-people-with-type-2-diabetes-and-painful-272https://curecurrent.com/trials/impact-glp-1-agonists-following-bariatric-273https://curecurrent.com/trials/a-randomized-phase-2-study-of-oral-bge-102-in-participants-with-center-involved-diabetic-macular-edema-274https://curecurrent.com/trials/a-safety-tolerability-and-efficacy-study-of-vx-264-in-participants-with-type-1-diabetes-275https://curecurrent.com/trials/a-research-study-to-see-how-much-cagrisema-lowers-blood-sugar-and-body-weight-compared-to-tirzepatide-in-people-with-typ-276https://curecurrent.com/trials/a-master-protocol-to-investigate-efficacy-and-safety-of-elecoglipron-in-participants-with-obesity-or-overweight-with-or-277https://curecurrent.com/trials/efficacy-and-safety-of-oral-kai-7535-in-adult-participants-living-with-obesity-or-overweight-with-at-least-1-weight-rela-278https://curecurrent.com/trials/a-research-study-to-look-at-how-semaglutide-compared-to-placebo-affects-diabetic-eye-disease-in-people-with-type-2-diabe-279https://curecurrent.com/trials/a-research-study-to-see-how-much-cagrisema-lowers-blood-sugar-and-body-weight-compared-to-placebo-in-people-with-type-2-280https://curecurrent.com/trials/dfc-004-biomarkers-for-active-diabetic-foot-ulcers-281https://curecurrent.com/trials/metabolic-and-bio-behavioral-effects-of-following-recommendations-in-the-dietary-guidelines-for-americans-282https://curecurrent.com/trials/presessions-for-the-national-diabetes-prevention-program-283https://curecurrent.com/trials/platform-trial-to-delay-stage-3-diabetes-comparing-teplizumab-with-atg-284https://curecurrent.com/trials/efficacy-and-safety-of-petrelintide-in-participants-with-overweight-or-obesity-and-type-2-diabetes-zupreme-2-285https://curecurrent.com/trials/integrating-a-prescription-produce-program-within-a-diabetes-prevention-program-286https://curecurrent.com/trials/placebo-controlled-proof-of-concept-study-to-evaluate-the-safety-and-efficacy-of-lanifibranor-alone-and-in-combination-w-287https://curecurrent.com/trials/a-study-to-find-out-if-the-study-drug-elecoglipron-helps-adults-with-type-2-diabetes-mellitus-by-comparing-it-with-semag-288https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-obicetrapib-ezetimibe-10-mg-fixed-dose-combination-or-obicetrapib-10-mg-daily-on-top-o-289https://curecurrent.com/trials/a-research-study-to-see-how-much-cagrisema-lowers-blood-sugar-and-body-weight-compared-to-placebo-in-children-and-adoles-290https://curecurrent.com/trials/improving-coronary-vascular-health-in-women-291https://curecurrent.com/trials/study-comparing-acceptance-and-commitment-therapy-to-supportive-diabetes-counseling-and-a-waitlist-control-for-eating-di-292https://curecurrent.com/trials/islet-function-in-gestational-diabetes-293https://curecurrent.com/trials/maternal-obesity-breast-milk-composition-and-infant-growth-294https://curecurrent.com/trials/rezpegaldesleukin-nktr-358-in-new-onset-type-1-diabetes-mellitus-295https://curecurrent.com/trials/neoadjuvant-pembrolizumab-and-porustobart-in-resectable-pmmr-mss-colon-cancer-296https://curecurrent.com/trials/c-carbs-a-cgm-guided-approach-to-teaching-carb-awareness-297https://curecurrent.com/trials/graded-insulin-suppression-test-p-f-298https://curecurrent.com/trials/early-detection-initiative-for-pancreatic-cancer-299https://curecurrent.com/trials/a-study-of-macupatide-ly3532226-and-eloralintide-ly3841136-alone-or-in-combination-in-adults-with-obesity-or-overweight-300https://curecurrent.com/trials/single-arm-intervention-trial-of-deka-twiist-tm-insulin-pump-utilizing-tidepool-loop-algorithm-in-pregnant-people-with-p-301https://curecurrent.com/trials/the-ilet-experience-study-302https://curecurrent.com/trials/testing-a-conversion-factor-for-a-more-rapidly-acting-insulin-in-an-automated-insulin-delivery-system-among-adolescents-303https://curecurrent.com/trials/inflammation-diabetes-ethnicity-and-obesity-cohort-304https://curecurrent.com/trials/a-research-study-to-see-how-much-cagrisema-lowers-blood-sugar-and-body-weight-compared-to-tirzepatide-in-people-with-typ-305https://curecurrent.com/trials/is-the-degree-of-perceived-effort-during-resistance-exercise-important-for-improvements-in-blood-glucose-306https://curecurrent.com/trials/promoting-alternatives-to-sulfonylureas-to-improve-patient-safety-in-type-2-diabetes-307https://curecurrent.com/trials/diabetic-foot-ulcer-imaging-study-2-308https://curecurrent.com/trials/a-community-health-worker-pharmacist-team-to-improve-blood-sugars-in-diabetes-care-using-continuous-glucose-monitoring-309https://curecurrent.com/trials/this-study-will-evaluate-cardiorespiratory-and-muscular-fitness-to-examine-associations-with-anthropometric-characterist-310https://curecurrent.com/trials/improving-appetite-self-regulation-in-african-american-adults-with-type-2-diabetes-311https://curecurrent.com/trials/a-study-of-orforglipron-in-adult-participants-with-obesity-or-overweight-and-type-2-diabetes-312https://curecurrent.com/trials/weight-loss-in-people-living-with-overweight-or-obesity-and-type-2-diabetes-following-treatment-with-cagrilintide-313https://curecurrent.com/trials/a-study-of-orforglipron-ly3502970-in-adult-participants-with-type-2-diabetes-and-inadequate-glycemic-control-with-diet-a-314https://curecurrent.com/trials/potatoes-type-2-diabetes-and-cardiometabolic-health-315https://curecurrent.com/trials/alpelisib-challenge-test-act-316https://curecurrent.com/trials/evaluation-of-a-mixed-meal-test-for-diagnosis-and-characterization-and-type-3c-diabetes-mellitus-secondary-to-pancreatic-317https://curecurrent.com/trials/ketogenic-diet-and-diabetes-demonstration-project-318https://curecurrent.com/trials/study-of-a-diabetes-prevention-patient-activation-clinical-decision-support-tool-319https://curecurrent.com/trials/evaluate-the-efficacy-of-an-oral-health-behavioral-intervention-in-people-with-diabetes-320https://curecurrent.com/trials/prenatal-exercise-and-glucose-regulation-321https://curecurrent.com/trials/effort-during-resistance-training-in-type-2-diabetes-322https://curecurrent.com/trials/peanuts-for-cardiometabolic-brain-and-intestinal-health-323https://curecurrent.com/trials/phase-2a-dose-finding-study-of-nu-3-gel-in-subjects-with-mild-idfu-324https://curecurrent.com/trials/wild-blueberries-for-gut-brain-and-cardiometabolic-health-in-prediabetes-325https://curecurrent.com/trials/enhancing-diabetes-care-by-treating-insomnia-326https://curecurrent.com/trials/evaluating-the-efficacy-of-perinatal-membrane-allografts-in-addition-to-the-standard-of-care-for-the-treatment-of-non-he-327https://curecurrent.com/trials/dexcom-continuous-glucose-monitoring-system-use-in-areal-world-global-registry-dexcom-global-registry-328https://curecurrent.com/trials/increasing-uptake-of-ehr-enabled-population-health-outreach-strategies-to-improve-diabetes-screening-329https://curecurrent.com/trials/a-phase-iii-study-to-investigate-the-efficacy-and-safety-of-elecoglipron-compared-with-placebo-in-adults-with-type-2-dia-330https://curecurrent.com/trials/care-d-foot-nav-pilot-331https://curecurrent.com/trials/impact-of-aromatase-inhibitor-therapy-on-glucose-homeostasis-and-diabetes-risk-332https://curecurrent.com/trials/optimizing-prescribing-decisions-for-hospitalized-older-adults-with-chronic-conditions-333https://curecurrent.com/trials/janus-kinase-jak-inhibitors-to-preserve-c-peptide-production-in-new-onset-type-1-diabetes-t1d-334https://curecurrent.com/trials/mindfulness-based-intervention-for-depression-and-insulin-resistance-in-adolescents-335https://curecurrent.com/trials/a-randomized-phase-1-2-trial-of-low-dose-anti-thymocyte-globulin-atg-with-subsequent-adalimumab-or-verapamil-in-new-onse-336https://curecurrent.com/trials/food-as-medicine-for-diabetes-337https://curecurrent.com/trials/a-randomized-controlled-trial-of-prepared-vs-unprepared-food-338https://curecurrent.com/trials/arizona-ceal-linking-social-care-with-healthcare-systems-to-address-sdoh-339https://curecurrent.com/trials/gateway-safety-evaluation-of-the-minimed-nmx8-aid-system-in-children-and-adults-living-with-diabetes-340https://curecurrent.com/trials/wild-blueberries-for-gut-brain-and-heart-health-in-adults-with-high-blood-pressure-341https://curecurrent.com/trials/phase-1-study-of-velgraft-a-living-cellular-construct-in-the-management-of-chronic-diabetic-foot-ulcers-which-have-attai-342https://curecurrent.com/trials/medically-tailored-meals-for-cardiovascular-health-343https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-rz402-in-diabetic-macular-edema-dme-344https://curecurrent.com/trials/ability-of-almonds-to-improve-nutrition-during-glp-1-treatment-345https://curecurrent.com/trials/ambition-7-a-research-study-investigating-how-well-zenagamtide-lowers-blood-sugar-and-body-weight-compared-to-insulin-gl-346https://curecurrent.com/trials/remedy-to-diabetes-distress-r2d2-a-scalable-screen-to-treat-program-for-school-age-families-347https://curecurrent.com/trials/food-as-medicine-for-hiv-and-diabetes-348https://curecurrent.com/trials/the-breakfast-study-349https://curecurrent.com/trials/mechanisms-of-fatigability-with-diabetes-350https://curecurrent.com/trials/a-study-to-test-if-trevogrumab-or-trevogrumab-with-garetosmab-when-taken-with-semaglutide-is-safe-and-how-well-they-work-351https://curecurrent.com/trials/rituximab-pvvr-and-abatacept-vs-rituximab-pvvr-alone-in-new-onset-type-1-diabetes-352https://curecurrent.com/trials/identifying-risk-for-diabetes-and-heart-disease-in-women-353https://curecurrent.com/trials/a-safety-tolerability-and-efficacy-study-of-vx-880-and-vx-017-in-participants-with-type-1-diabetes-354https://curecurrent.com/trials/a-long-term-follow-up-study-of-participants-exposed-to-react-355https://curecurrent.com/trials/ps230005-control-iq-1-5-post-approval-study-356https://curecurrent.com/trials/strong-relationships-to-improve-diabetes-pilot-357https://curecurrent.com/trials/a-phase-iii-study-to-investigate-the-efficacy-and-safety-of-elecoglipron-alone-or-in-combination-with-dapagliflozin-comp-358https://curecurrent.com/trials/a-phase-iii-study-to-investigate-the-efficacy-and-safety-of-the-combination-of-elecoglipron-and-dapagliflozin-in-adults-359https://curecurrent.com/trials/feasibility-study-of-extended-wear-insulin-infusion-set-options-during-home-use-in-people-with-type-1-diabetes-360https://curecurrent.com/trials/the-effects-of-mirabegron-and-tadalafil-on-glucose-tolerance-in-prediabetics-361https://curecurrent.com/trials/the-pivot-trial-project-on-ehr-integrated-lifestyle-interventions-for-adults-aged-fifty-and-older-362https://curecurrent.com/trials/oral-anti-diabetic-agents-in-the-hospital-363https://curecurrent.com/trials/a-study-of-oral-ladarixin-in-recent-onset-type-1-diabetes-and-a-low-residual-cell-function-364https://curecurrent.com/trials/how-fig-polyphenols-affect-blood-sugar-and-insulin-levels-after-eating-in-adults-at-risk-for-diabetes-365https://curecurrent.com/trials/risk-communication-within-mexican-american-families-366https://curecurrent.com/trials/community-pharmacy-produce-prescriptions-367https://curecurrent.com/trials/a-study-of-ly3549492-in-adults-with-obesity-or-overweight-with-type-2-diabetes-368https://curecurrent.com/trials/early-versus-late-adjunctive-vasopressin-in-septic-shock-369https://curecurrent.com/trials/dorzagliatin-in-pancreatic-insufficient-cystic-fibrosis-370https://curecurrent.com/trials/randomized-pilot-trial-of-ayuda-program-for-younger-latinx-adults-with-type-2-diabetes-371https://curecurrent.com/trials/enlight-trial-esg-with-fundal-mucosal-ablation-372https://curecurrent.com/trials/safety-evaluation-of-modi-an-insulin-titration-algorithm-in-adults-with-diabetes-373https://curecurrent.com/trials/risk-informed-shared-decision-making-engagement-strategy-for-patients-with-prediabetes-374https://curecurrent.com/trials/hla-demographics-study-in-adults-with-type-1-diabetes-375https://curecurrent.com/trials/optimizing-mango-s-glycemic-impact-investigating-mango-consumption-timing-in-prediabetic-individuals-376https://curecurrent.com/trials/can-mindfulness-and-virtual-reality-reduce-stress-in-young-adults-with-type-1-diabetes-377https://curecurrent.com/trials/phase-2-trial-of-bmf-219-in-participants-with-type-1-diabetes-mellitus-378https://curecurrent.com/trials/clinical-utility-of-an-amniotic-membrane-allograft-for-diabetic-foot-ulcer-wound-management-379https://curecurrent.com/trials/hmb-plus-vitamin-d-to-preserve-muscle-in-older-adults-starting-semaglutide-380https://curecurrent.com/trials/understanding-dose-related-effects-of-strawberry-381https://curecurrent.com/trials/meganatural-bp-gse-on-blood-pressure-and-cardiometabolic-risk-factors-382https://curecurrent.com/trials/phase-2-trial-of-icovamenib-in-participants-with-type-2-diabetes-who-are-not-achieving-glycemic-targets-383https://curecurrent.com/trials/a-study-to-investigate-the-effect-of-elecoglipron-on-rosuvastatin-and-atorvastatin-in-healthy-participants-384https://curecurrent.com/trials/family-model-diabetes-self-management-education-in-faith-based-organizations-385https://curecurrent.com/trials/mitigating-dka-in-type-1-diabetes-for-safe-use-of-sglt-inhibitors-using-dual-continuous-ketone-and-glucose-monitoring-386https://curecurrent.com/trials/pilot-implementation-trial-of-implementation-toolkits-for-diabetes-coaching-387https://curecurrent.com/trials/trial-of-cgm-technology-in-persons-living-with-prediabetes-388https://curecurrent.com/trials/family-intervention-for-black-teens-with-type-1-diabetes-389https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-dehydrated-human-placenta-tissue-dhpt-for-wound-healing-390https://curecurrent.com/trials/generic-drugs-dapagliflozin-and-saxagliptin-treat-type-2-diabetes-patients-with-controlled-cancers-391https://curecurrent.com/trials/sleep-optimization-to-improve-glycemic-control-in-adults-with-type-1-diabetes-392https://curecurrent.com/trials/play2control-study-393https://curecurrent.com/trials/novel-digital-patient-reported-outcomes-tool-for-diabetes-management-394https://curecurrent.com/trials/care-partner-assisted-diabetes-self-management-through-linking-continuous-glucose-monitoring-with-mobile-health-improvin-395https://curecurrent.com/trials/hope-intervention-for-fitness-396https://curecurrent.com/trials/lifestyle-interventions-to-improve-glycemic-parameters-and-reduce-gestational-diabetes-in-high-risk-pregnant-individuals-397https://curecurrent.com/trials/aim-3-optimizing-crc-screening-in-patients-with-diabetes-in-safety-net-primary-care-settings-398https://curecurrent.com/trials/a-phase-iii-study-to-investigate-if-the-study-drug-diamyd-can-preserve-insulin-production-and-improve-glycemic-control-i-399https://curecurrent.com/trials/feasibility-of-a-diabetes-self-management-program-with-continuous-glucose-monitoring-for-adults-with-type-2-diabetes-400https://curecurrent.com/trials/effects-of-hbo-on-glucose-in-patients-with-dm-401https://curecurrent.com/trials/extension-study-to-evaluate-the-safety-of-long-term-use-of-relacorilant-in-patients-with-cushing-syndrome-402https://curecurrent.com/trials/a-study-to-identify-and-characterize-patients-with-type-2-diabetes-mellitus-for-possible-participation-in-ongoing-or-fut-403https://curecurrent.com/trials/minimed-fit-payload-wear-pediatric-study-404https://curecurrent.com/trials/long-term-outcomes-of-teplizumab-in-routine-clinical-care-405https://curecurrent.com/trials/a-study-to-evaluate-effect-of-azd6234-in-adult-participants-with-obesity-or-overweight-with-weight-related-comorbidity-w-406https://curecurrent.com/trials/brown-adipose-tissue-activation-by-spinal-cord-stimulation-407https://curecurrent.com/trials/whole-gut-motility-abnormalities-following-glp-1-receptor-agonist-glp-1ra-initiation-408https://curecurrent.com/trials/preventing-type-2-diabetes-in-black-emergent-adult-409https://curecurrent.com/trials/diabetes-toolkit-at-discharge-410https://curecurrent.com/trials/hormonal-responses-to-a-mixed-meal-in-people-with-cystic-fibrosis-411https://curecurrent.com/trials/a-study-of-htd1801-in-adults-with-nonalcoholic-steatohepatitis-nash-and-type-2-diabetes-mellitus-t2dm-412https://curecurrent.com/trials/a-study-of-lower-radiotherapy-dose-to-treat-children-with-cns-germinoma-413https://curecurrent.com/trials/preventative-screening-and-health-coaching-in-a-food-insecure-population-414https://curecurrent.com/trials/safety-and-efficacy-of-human-anti-thymocyte-immunoglobulin-sab-142-arresting-progression-of-type-1-diabetes-415https://curecurrent.com/trials/metformin-for-preeclampsia-prevention-in-pregnant-women-with-type-1-diabetes-mellitus-416https://curecurrent.com/trials/human-models-of-selective-insulin-resistance-alpelisib-part-i-417https://curecurrent.com/trials/renal-hemodynamics-energetics-and-insulin-resistance-a-follow-up-study-418https://curecurrent.com/trials/oral-mucosa-wound-healing-after-gingival-recession-treatment-in-diabetic-patients-a-clinical-study-419https://curecurrent.com/trials/use-of-empagliflozin-to-treat-prediabetes-420https://curecurrent.com/trials/liver-transplant-cgm-421https://curecurrent.com/trials/mechanisms-of-ultrasound-neuromodulation-effects-in-diabetes-422https://curecurrent.com/trials/palatal-wound-healing-after-free-gingival-graft-harvest-in-diabetic-patients-a-clinical-trial-423https://curecurrent.com/trials/role-of-finerenone-in-african-american-veterans-with-diabetic-kidney-disease-424https://curecurrent.com/trials/the-effects-of-cognitive-behavioral-therapy-on-insulin-resistance-in-people-with-hiv-425https://curecurrent.com/trials/4d-150-in-patients-with-diabetic-macular-edema-426https://curecurrent.com/trials/patient-comfort-following-intravitreal-injections-using-iheezo-versus-standard-anesthesia-427https://curecurrent.com/trials/evaluation-of-an-intervention-for-young-adults-with-diabetes-resilient-empowered-active-living-telehealth-real-t-428https://curecurrent.com/trials/a-study-of-retatrutide-ly3437943-in-participants-who-have-obesity-or-overweight-429https://curecurrent.com/trials/pns-to-improve-vascular-function-and-limb-health-in-veterans-430https://curecurrent.com/trials/a-study-to-investigate-safety-and-effectiveness-of-porcine-pancreatic-cells-opf-310-in-patients-with-type-1-diabetes-mel-431https://curecurrent.com/trials/group-versus-traditional-prenatal-care-for-diabetes-432https://curecurrent.com/trials/inflammatory-mediators-in-the-pathophysiology-of-diabetic-retinopathy-study-433https://curecurrent.com/trials/lean-beef-as-part-of-a-healthy-meal-plan-in-adolescents-with-polycystic-ovary-syndrome-pcos-polyendocrine-metabolic-ovar-434https://curecurrent.com/trials/prepup-a-randomized-trial-of-bonvadis-versus-collagenase-ointment-in-diabetic-foot-ulcers-435https://curecurrent.com/trials/the-gut-microbiome-in-type-1-diabetes-and-mechanism-of-metformin-action-436https://curecurrent.com/trials/a-research-study-to-compare-a-new-medicine-oral-semaglutide-to-a-dummy-medicine-in-children-and-teenagers-with-type-2-di-437https://curecurrent.com/trials/targeting-type-1-diabetes-using-polyamines-tadpol-438https://curecurrent.com/trials/phipps-conservatory-s-5210-let-s-move-pittsburgh-and-impact-on-youth-with-t1d-439https://curecurrent.com/trials/identifying-oxytocin-deficiency-in-pediatric-patients-with-pituitary-disease-440https://curecurrent.com/trials/impact-of-per-oral-pyloromyotomy-pop-on-glycemic-control-in-diabetes-441https://curecurrent.com/trials/a-study-to-evaluate-medi5752-in-subjects-with-advanced-solid-tumors-442https://curecurrent.com/trials/nonhealing-diabetic-foot-ulcers-treated-with-standard-of-care-soc-alone-or-standard-of-care-and-amnion-intermediate-chor-443https://curecurrent.com/trials/evaluating-the-inpen-in-pediatric-type-1-diabetes-444https://curecurrent.com/trials/glycated-albumin-monitoring-445https://curecurrent.com/trials/t1d-pregnancy-me-446https://curecurrent.com/trials/targeting-metabolic-syndrome-from-the-emergency-department-through-mixed-methods-pilot-trial-447https://curecurrent.com/trials/a-study-of-ly4086940-in-healthy-participants-and-participants-with-overweight-or-obesity-with-or-without-type-2-diabetes-448https://curecurrent.com/trials/mtm2mtg-pilot-ancillary-study-449https://curecurrent.com/trials/fitbit-and-ai-chatbot-in-sedentary-primary-care-patients-with-t2d-450https://curecurrent.com/trials/rgx-314-gene-therapy-administered-in-the-suprachoroidal-space-for-participants-with-diabetic-retinopathy-dr-with-and-wit-451https://curecurrent.com/trials/embedded-primary-care-multidisciplinary-diabetes-clinic-452https://curecurrent.com/trials/fgf-1-for-topical-administration-for-the-treatment-of-diabetic-or-venous-stasis-ulcers-453https://curecurrent.com/trials/app-mnt-app-enhanced-medical-nutrition-therapy-on-glycemic-outcomes-and-quality-of-life-454https://curecurrent.com/trials/impact-of-removable-cast-walker-design-on-usability-for-patients-with-diabetic-foot-ulcers-455https://curecurrent.com/trials/pa-moves-trial-patient-participants-456https://curecurrent.com/trials/specimen-and-data-collection-in-south-carolina-medicaid-enrolled-patients-with-type-2-diabetes-t2d-and-metabolically-hea-457https://curecurrent.com/trials/effect-of-short-term-beta-cell-rest-in-adolescents-and-young-adults-with-type-2-diabetes-mellitus-458https://curecurrent.com/trials/biomarkers-during-pregnancy-459https://curecurrent.com/trials/links-between-inflammation-and-cardiometabolic-diseases-460https://curecurrent.com/trials/delta-greens-food-is-medicine-intervention-461https://curecurrent.com/trials/the-ymca-healthy-lifestyle-program-for-prediabetes-462https://curecurrent.com/trials/walking-function-in-diabetic-peripheral-neuropathy-463https://curecurrent.com/trials/personalized-comprehensive-diabetes-support-for-children-with-newly-diagnosed-type-1-diabetes-464https://curecurrent.com/trials/vitamin-d-and-type-2-diabetes-treat-to-target-465https://curecurrent.com/trials/feasibility-testing-an-exercise-program-to-improve-cognition-for-t2dm-patients-466https://curecurrent.com/trials/quantifying-hepatic-mitochondrial-fluxes-in-humans-467https://curecurrent.com/trials/role-of-adiposomes-in-endothelial-dysfunction-468https://curecurrent.com/trials/study-to-understand-risk-information-to-support-and-empower-469https://curecurrent.com/trials/study-to-evaluate-hm15275-in-subjects-with-type-2-diabetes-mellitus-470https://curecurrent.com/trials/at-home-exercise-study-for-veterans-with-healed-diabetic-foot-ulcers-471https://curecurrent.com/trials/diabetes-management-using-continuous-glucose-monitors-and-remote-patient-monitoring-in-underserved-populations-472https://curecurrent.com/trials/pilot-of-continuous-glucose-monitor-augmented-food-is-medicine-473https://curecurrent.com/trials/diabetes-multimorbidity-typology-trajectory-and-feasibility-of-an-audio-diary-mobile-application-to-support-self-managem-474https://curecurrent.com/trials/cardiometabolic-impact-of-a-produce-prescription-program-in-patients-with-type-2-diabetes-and-food-insecurity-475https://curecurrent.com/trials/nourish-a-healthcare-community-partnership-to-improve-nutrition-for-optimal-glycemic-control-and-pregnancy-outcomes-with-476https://curecurrent.com/trials/evaluating-telementoring-for-chw-centered-diabetes-initiatives-477https://curecurrent.com/trials/preventing-t2dm-after-gdm-with-immediate-postpartum-screening-478https://curecurrent.com/trials/intrapartum-glucose-control-and-risk-of-neonatal-hypoglycemia-479https://curecurrent.com/trials/arginine-metabolism-in-youth-with-type-2-diabetes-480https://curecurrent.com/trials/decision-impact-trial-of-kidneyintelx-481https://curecurrent.com/trials/comparative-effectiveness-and-safety-of-four-second-line-pharmacological-strategies-in-type-2-diabetes-study-482https://curecurrent.com/trials/dysvascular-amputation-self-management-of-health-483https://curecurrent.com/trials/validating-cgm-for-gdm-484https://curecurrent.com/trials/prospective-decision-impact-trial-of-kidneyintelx-485https://curecurrent.com/trials/sweetgoals-for-type-1-diabetes-486https://curecurrent.com/trials/miro3d-wound-matrix-for-treatment-of-diabetic-foot-ulcers-487https://curecurrent.com/trials/subclinical-primary-aldosteronism-in-diabetes-at-risk-for-kidney-disease-488https://curecurrent.com/trials/real-fam-feasibility-study-for-youth-diabetes-management-489https://curecurrent.com/trials/inhale-1st-afrezza-for-youth-with-newly-diagnosed-type-1-diabetes-490https://curecurrent.com/trials/adaptive-dietary-intervention-adi-for-asian-americans-with-type-2-diabetes-491https://curecurrent.com/trials/real-world-evidence-clinical-utility-study-of-kidneyintelx-492https://curecurrent.com/trials/prospective-decision-impact-clinical-utility-trial-of-kidneyintelx-493https://curecurrent.com/trials/a-study-to-investigate-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-azd4248-in-healthy-participants-and-494https://curecurrent.com/trials/htd1801-in-adults-with-nonalcoholic-steatohepatitis-and-liver-fibrosis-who-have-type-2-diabetes-or-pre-diabetes-495https://curecurrent.com/trials/accessing-care-clinical-trials-and-screening-for-underserved-children-and-adults-with-type-1-diabetes-access-t1d-496https://curecurrent.com/trials/acute-exercise-and-endogenous-glucose-production-in-type-2-diabetes-implications-for-glycemic-control-and-treatment-of-h-497https://curecurrent.com/trials/changing-the-natural-history-of-type-2-diabetes-change-study-498https://curecurrent.com/trials/non-healing-diabetic-foot-ulcers-treated-with-standard-care-with-or-without-br-am-499https://curecurrent.com/trials/therapeutic-strategies-for-microvascular-dysfunction-in-type-1-diabetes-500https://curecurrent.com/trials/integrating-cultural-aspects-into-diabetes-education-501https://curecurrent.com/trials/effect-of-exercise-and-or-liraglutide-on-vascular-dysfunction-and-insulin-sensitivity-in-type-2-diabetes-zql007-502https://curecurrent.com/trials/a-novel-digital-tool-physicians-can-use-to-prescribe-exercise-to-patients-with-cardiovascular-disease-risk-factors-503https://curecurrent.com/trials/using-a-personalized-decision-support-tool-to-help-people-with-type-1-diabetes-manage-exercise-504https://curecurrent.com/trials/digital-health-navigation-for-latino-patients-with-type-ii-diabetes-505https://curecurrent.com/trials/this-study-is-to-determine-if-inhaled-insulin-is-effective-in-treating-type-2-diabetes-mellitus-506https://curecurrent.com/trials/a-research-study-to-compare-a-new-weekly-insulin-insulin-icodec-used-with-doseguide-app-and-daily-insulins-in-people-wit-507https://curecurrent.com/trials/reduction-of-nocturnal-hypoglycemia-and-hyperglycemia-in-the-home-using-predictive-algorithms-508https://curecurrent.com/trials/proact-a-study-of-react-in-subjects-with-type-2-diabetes-mellitus-and-chronic-kidney-disease-509https://curecurrent.com/trials/continuous-glucose-monitoring-cgm-in-people-with-type-2-diabetes-not-on-insulin-510https://curecurrent.com/trials/a-research-study-to-see-how-switching-from-a-daily-basal-insulin-to-a-new-weekly-insulin-insulin-icodec-helps-in-reducin-511https://curecurrent.com/trials/supporting-medtronic-780g-insulin-pump-adoption-in-latino-patients-a-spanish-language-training-initiative-512https://curecurrent.com/trials/food-insecurity-reduction-strategy-team-513https://curecurrent.com/trials/cgm-after-discharge-from-hospital-514https://curecurrent.com/trials/role-of-katp-channel-loss-in-type-2-diabetes-515https://curecurrent.com/trials/effect-of-dairy-consumption-on-glycemic-control-body-weight-and-cardiovascular-risk-factors-516https://curecurrent.com/trials/the-rest-study-for-cgm-use-in-older-adults-with-insulin-treated-diabetes-517https://curecurrent.com/trials/exciflex-electroceutical-banadage-for-chronic-wound-therapy-518https://curecurrent.com/trials/circadian-rhythms-in-postmenopausal-women-519https://curecurrent.com/trials/optimizing-lifestyles-through-increased-vegetable-rich-eating-pilot-study-520https://curecurrent.com/trials/a-research-study-comparing-rybelsus-to-other-blood-sugar-lowering-tablets-in-people-living-in-america-with-type-2-diabet-521https://curecurrent.com/trials/opt101-in-type-1-diabetes-patients-522https://curecurrent.com/trials/precision-t1d-platform-new-therapies-for-cardio-renal-complications-523https://curecurrent.com/trials/a-study-of-gnti-122-in-adults-recently-diagnosed-with-t1d-524https://curecurrent.com/trials/improving-cervical-cancer-prevention-among-women-living-with-chronic-conditions-525https://curecurrent.com/trials/expanding-the-support-of-family-caregivers-of-diverse-patients-with-cancer-and-diabetes-526https://curecurrent.com/trials/pharmacist-led-continuous-glucose-monitoring-for-prediabetes-527https://curecurrent.com/trials/a-study-of-dulaglutide-ly2189265-3-0-mg-and-4-5-mg-in-pediatric-participants-with-type-2-diabetes-mellitus-award-peds-pl-528https://curecurrent.com/trials/improving-transition-care-for-adolescents-and-young-adults-with-type-1-diabetes-529https://curecurrent.com/trials/diazoxide-suppression-test-p-f-study-530https://curecurrent.com/trials/michigan-men-s-diabetes-project-2-531https://curecurrent.com/trials/cgm-and-lifestyle-changes-in-patients-with-impaired-glucose-tolerance-532https://curecurrent.com/trials/the-effect-of-clinic-visit-audio-recordings-for-self-management-in-older-adults-533https://curecurrent.com/trials/effect-of-2-week-continuous-glucose-monitoring-on-glycemic-management-in-patients-new-to-insulin-on-hospital-discharge-534https://curecurrent.com/trials/time-limited-eating-in-adolescents-with-type-2-diabetes-kt2d-535https://curecurrent.com/trials/the-groceries-aimed-at-increasing-nutrition-study-536https://curecurrent.com/trials/harnessing-macrophage-lysosomal-lipid-metabolism-in-obesity-atm-537https://curecurrent.com/trials/recreational-basketball-to-increase-participation-in-diabetes-prevention-538https://curecurrent.com/trials/qbsafe-a-randomized-trial-of-a-novel-intervention-to-improve-care-for-people-living-with-type-2-diabetes-539https://curecurrent.com/trials/a-study-to-test-whether-survodutide-bi-456906-helps-people-living-with-overweight-or-obesity-who-also-have-diabetes-to-l-540https://curecurrent.com/trials/growth-hormone-resistance-of-beta-cells-541https://curecurrent.com/trials/exploring-the-anti-inflammatory-properties-of-cannabis-and-their-relevance-to-insulin-sensitivity-542https://curecurrent.com/trials/improving-patient-centered-care-for-underserved-older-african-american-patients-with-cardiovascular-comorbidities-543https://curecurrent.com/trials/harnessing-macrophage-lysosomal-lipid-metabolism-in-obesity-544https://curecurrent.com/trials/thrive-with-type-1-diabetes-2026-545https://curecurrent.com/trials/long-term-follow-up-study-of-rgx-314-administered-in-the-suprachoroidal-space-for-participants-with-and-without-diabetic-546https://curecurrent.com/trials/circadian-intervention-to-improve-cardiometabolic-health-547https://curecurrent.com/trials/families-implementing-good-health-traditions-for-life-548https://curecurrent.com/trials/impact-of-insulin-deprivation-and-hyperglycemia-on-plasma-protein-synthesis-in-people-with-type-1-diabetes-mellitus-549https://curecurrent.com/trials/studies-of-insulin-and-glucagon-action-in-the-liver-550https://curecurrent.com/trials/promoting-intergenerational-health-in-rural-kentuckians-with-diabetes-pihrk-d-551https://curecurrent.com/trials/role-of-a-cck-receptor-antagonist-proglumide-in-management-of-chronic-pancreatitis-552https://curecurrent.com/trials/effect-of-sleep-extension-on-ceramides-in-people-with-overweight-and-obesity-553https://curecurrent.com/trials/safety-and-effectiveness-of-endoscopic-intestinal-re-cellularization-therapy-in-individuals-with-type-ii-diabetes-554https://curecurrent.com/trials/lowering-the-impact-of-food-insecurity-in-african-american-adults-with-type-2-diabetes-mellitus-lift-dm-555https://curecurrent.com/trials/leveraging-interventions-for-needs-and-knowledge-in-diabetes-linkd-556https://curecurrent.com/trials/impact-of-food-as-medicine-glycemic-control-at-two-large-academic-medical-centers-557https://curecurrent.com/trials/evaluating-the-efficacy-of-ocm-omeza-complete-matrix-in-the-treatment-of-diabetic-foot-ulcers-558https://curecurrent.com/trials/a-phase-iii-study-to-investigate-the-efficacy-and-safety-of-elecoglipron-compared-with-placebo-in-adults-with-type-2-dia-559https://curecurrent.com/trials/outcomes-of-physiologic-insulin-resensitization-pir-in-patients-with-chronic-kidney-disease-and-type-2-diabetes-mellitus-560https://curecurrent.com/trials/human-immunodeficiency-virus-hiv-food-insecurities-561https://curecurrent.com/trials/reset-enhancing-weight-loss-in-a-digital-intervention-562https://curecurrent.com/trials/polypill-for-prevention-of-cardiomyopathy-563https://curecurrent.com/trials/safer-aging-with-diabetes-monitoring-564https://curecurrent.com/trials/obesity-complicating-type-1-diabetes-glp-1-analogue-anti-obesity-treatment-565https://curecurrent.com/trials/glucose-metabolism-in-cystic-fibrosis-related-diabetes-cfrd-566https://curecurrent.com/trials/efficacy-of-the-omnipod-6-system-compared-with-the-omnipod-5-system-567https://curecurrent.com/trials/application-of-time-restriction-feeding-in-patients-with-type-2-diabetes-mellitus-568https://curecurrent.com/trials/a-trial-evaluating-amg-127-in-healthy-participants-and-participants-with-type-2-diabetes-mellitus-569https://curecurrent.com/trials/investigating-the-impact-of-glp-1-ra-therapy-on-osteosarcopenia-in-older-female-adults-with-diabetes-570https://curecurrent.com/trials/continuous-glucose-monitor-use-in-pregnancy-571https://curecurrent.com/trials/study-of-wal0921-in-patients-with-glomerular-kidney-diseases-572https://curecurrent.com/trials/continuous-glucose-metrics-in-patients-with-gastroparesis-in-type-1-or-type-2-diabetes-573https://curecurrent.com/trials/vasopressin-for-septic-shock-pragmatic-trial-574https://curecurrent.com/trials/evaluation-of-the-fully-closed-loop-omnipod-system-in-type-2-diabetes-575https://curecurrent.com/trials/cardiovascular-outcomes-in-bariatric-surgery-patients-with-type-2-diabetes-576https://curecurrent.com/trials/a-study-in-adult-males-with-x-linked-congenital-nephrogenic-diabetes-insipidus-to-test-the-effects-of-ndi-5001-given-for-577https://curecurrent.com/trials/a-master-protocol-for-orforglipron-ly3502970-in-participants-with-obesity-or-overweight-with-and-without-type-2-diabetes-578https://curecurrent.com/trials/time-restricted-eating-for-patients-with-type-2-diabetes-579https://curecurrent.com/trials/continuous-glucose-monitoring-and-ogtt-screen-for-cystic-fibrosis-related-diabetes-in-cystic-fibrosis-580https://curecurrent.com/trials/phase-2b-trial-comparing-hdv-insulin-lispro-to-insulin-lispro-in-adults-with-type-1-diabetes-receiving-insulin-degludec-581https://curecurrent.com/trials/the-influence-of-time-restricted-eating-in-patients-with-metabolic-syndrome-582https://curecurrent.com/trials/echo-for-diabetes-and-multiple-chronic-conditions-study-583https://curecurrent.com/trials/telehealth-music-therapy-for-adults-with-endocrine-disorder-and-depression-584https://curecurrent.com/trials/a-study-of-retatrutide-ly3437943-in-participants-with-type-2-diabetes-mellitus-who-have-obesity-or-overweight-585https://curecurrent.com/trials/diabetes-prevention-program-outcomes-study-586https://curecurrent.com/trials/role-of-et-1-physical-activity-and-sedentary-behavior-in-microvascular-dysfunction-following-gdm-587https://curecurrent.com/trials/role-of-nadph-oxidase-in-microvascular-dysfunction-following-gdm-588https://curecurrent.com/trials/pioglitazone-versus-empagliflozin-for-chronic-pancreatitis-recurrent-acute-pancreatitis-acute-pancreatitis-associated-di-589https://curecurrent.com/trials/a-study-of-the-safety-of-mibavademab-in-pediatric-and-adult-participants-switching-from-metreleptin-to-mibavademab-for-t-590https://curecurrent.com/trials/dapagliflozin-plus-pioglitazone-in-t1dm-591https://curecurrent.com/trials/oxidative-stress-in-microvascular-dysfunction-following-gestational-diabetes-592https://curecurrent.com/trials/a-study-of-orforglipron-ly3502970-in-participants-with-obesity-or-overweight-and-at-least-one-weight-related-comorbidity-593https://curecurrent.com/trials/uric-acid-lowering-trial-in-youth-onset-t2d-594https://curecurrent.com/trials/a-sugar-sweetened-beverage-reduction-intervention-for-native-american-men-595https://curecurrent.com/trials/salud-m-acceptance-based-coping-skills-for-hispanic-latinx-military-patients-with-type-2-diabetes-596https://curecurrent.com/trials/nautical-effect-of-natriuretic-peptide-augmentation-on-cardiometabolic-health-in-black-individuals-597https://curecurrent.com/trials/siplizumab-in-t1dm-598https://curecurrent.com/trials/denosumab-for-type-1-diabetes-599https://curecurrent.com/trials/cadisegliatin-as-adjunctive-therapy-to-insulin-in-participants-with-type-1-diabetes-600https://curecurrent.com/trials/commercial-or-open-source-closed-loop-impact-on-pregnancy-study-601https://curecurrent.com/trials/pharmacogenetics-of-response-to-glp1r-agonists-602https://curecurrent.com/trials/a-modified-platform-trial-of-multiple-camps-for-the-management-of-diabetic-foot-ulcers-and-venous-leg-ulcers-603https://curecurrent.com/trials/randomized-double-blind-study-comparing-tremelimumab-to-placebo-in-subjects-with-unresectable-malignant-mesothelioma-604https://curecurrent.com/trials/adapting-single-sessions-interventions-for-type-1-diabetes-605https://curecurrent.com/trials/financial-incentives-and-nurse-coaching-to-enhance-diabetes-outcomes-finance-dm-1-606https://curecurrent.com/trials/determination-of-resistance-training-status-for-patients-on-glucagon-like-peptide-1-receptor-agonists-607https://curecurrent.com/trials/biomarker-of-diabetic-retinopathy-608https://curecurrent.com/trials/improving-how-older-adults-at-risk-for-cardiovascular-outcomes-are-selected-for-care-coordination-609https://curecurrent.com/trials/physiologic-markers-of-cardiometabolic-risk-in-people-with-type-1-diabetes-610https://curecurrent.com/trials/dietary-insights-and-nutrition-experiences-in-adults-on-glp-1-therapy-a-study-on-diet-quality-changes-in-adults-on-glp-1-611https://curecurrent.com/trials/spinal-cord-stimulation-and-small-fiber-peripheral-neuropathy-612https://curecurrent.com/trials/enhancing-diabetes-management-approaches-for-patients-with-uncontrolled-diabetes-613https://curecurrent.com/trials/effects-of-intranasal-oxytocin-in-patients-with-arginine-vasopressin-deficiency-614https://curecurrent.com/trials/sglt2i-therapy-in-islet-transplantation-sit-615https://curecurrent.com/trials/active-you-walk-dance-and-tone-your-abs-to-reduce-your-risk-of-diabetes-616https://curecurrent.com/trials/clinical-trial-evaluating-the-safety-tolerability-and-preliminary-efficacy-of-bnt116-alone-and-in-combinations-in-patien-617https://curecurrent.com/trials/building-and-sustaining-exercise-habits-for-adults-with-type-1-diabetes-618https://curecurrent.com/trials/video-intervention-to-improve-understanding-of-diabetic-retinopathy-at-zuckerberg-san-francisco-general-hospital-and-tra-619https://curecurrent.com/trials/effectiveness-of-remote-foot-temperature-monitoring-620https://curecurrent.com/trials/cgm-use-in-heart-failure-621https://curecurrent.com/trials/comparative-effectiveness-of-empagliflozin-in-the-us-622https://curecurrent.com/trials/continuous-glucose-monitoring-following-hospital-discharge-623https://curecurrent.com/trials/iron-depletion-therapy-for-type-2-dm-and-nafld-624https://curecurrent.com/trials/comparison-of-10-khz-scs-combined-with-cmm-to-cmm-alone-in-the-treatment-of-neuropathic-limb-pain-625https://curecurrent.com/trials/the-t1d-parent-check-in-a-preventative-intervention-626https://curecurrent.com/trials/gestational-diabetes-and-pharmacotherapy-gap-627https://curecurrent.com/trials/effect-of-retatrutide-compared-with-placebo-in-participants-with-type-2-diabetes-and-moderate-or-severe-renal-impairment-628https://curecurrent.com/trials/breaking-disparities-in-access-to-advanced-diabetes-technologies-in-children-with-type-1-diabetes-629https://curecurrent.com/trials/cardiometabolic-cognitive-effects-of-peanut-butter-in-prediabetes-630https://curecurrent.com/trials/transcutaneous-electrical-acustimulation-tea-for-gastroparesis-631https://curecurrent.com/trials/nutrition-intervention-optimization-to-better-utilize-resources-and-support-health-632https://curecurrent.com/trials/phase-2a-multi-center-prospective-randomized-trial-to-evaluate-the-safety-efficacy-of-topical-pep-tisseel-for-diabetic-f-633https://curecurrent.com/trials/randomized-ehr-based-prescribing-to-improve-disease-modifying-therapies-for-cardio-kidney-metabolic-care-rapid-ckm-634https://curecurrent.com/trials/preventing-obstetric-complications-with-dietary-intervention-635https://curecurrent.com/trials/skeletal-muscle-diacylglycerol-and-sphingolipids-impact-of-localization-and-species-on-insulin-resistance-in-humans-636https://curecurrent.com/trials/smart-walk-a-culturally-tailored-smartphone-delivered-physical-activity-intervention-for-african-american-women-637https://curecurrent.com/trials/sglt2i-pioglitazone-and-ketone-production-in-t2d-638https://curecurrent.com/trials/sglti-hepatic-glucose-production-and-ketogenesis-639https://curecurrent.com/trials/sglt2i-hepatic-glucose-production-and-sns-640https://curecurrent.com/trials/semaglutide-treatment-in-the-real-world-for-fibrosis-due-to-nafld-in-obesity-and-t2dm-641https://curecurrent.com/trials/eating-almonds-before-a-meal-to-control-blood-sugar-642https://curecurrent.com/trials/military-health-and-nutrition-examination-study-643https://curecurrent.com/trials/sglt2i-ketoacidosis-volume-contraction-and-insulinopenia-644https://curecurrent.com/trials/peer-i-coaching-for-activated-self-management-optimization-in-adolescents-and-young-adults-with-chronic-conditions-645https://curecurrent.com/trials/efficacy-and-safety-of-gzr18-every-2-weeks-versus-tirzepatide-and-placebo-in-obese-or-overweight-participants-646https://curecurrent.com/trials/effect-of-inhaled-technosphere-insulin-vs-raa-insulin-on-exercise-induced-hypoglycemia-in-adults-with-t1d-using-automate-647https://curecurrent.com/trials/pilot-study-of-bottarga-supplementation-a-little-known-sustainable-blue-food-648https://curecurrent.com/trials/a-study-to-evaluate-continuous-glucose-monitor-in-hospitalized-post-operative-patients-with-diabetes-mellitus-649https://curecurrent.com/trials/individualized-diabetes-education-assisted-by-cgm-idea-cgm-650https://curecurrent.com/trials/evaluation-of-superiority-of-valsartan-celecoxib-metformin-over-metformin-alone-in-type-2-diabetes-patients-651https://curecurrent.com/trials/screening-for-social-determinants-of-health-in-routine-diabetes-care-652https://curecurrent.com/trials/inpatient-use-of-personal-continuous-glucose-monitor-cgm-to-improve-diabetes-mellitus-control-653https://curecurrent.com/trials/social-risk-score-clinical-decision-support-tool-and-closed-loop-referral-for-social-risk-screen-and-referral-654https://curecurrent.com/trials/empowering-faith-based-communities-to-provide-personalized-diabetes-self-management-education-and-support-dsmes-in-the-m-655https://curecurrent.com/trials/efficacy-and-safety-of-ribupatide-kai-9531-administered-once-weekly-in-participants-living-with-obesity-who-do-not-have-656https://curecurrent.com/trials/understanding-and-addressing-risks-of-low-socioeconomic-status-and-diabetes-for-heart-failure-657https://curecurrent.com/trials/wearable-insoles-for-recurrent-diabetic-ulcer-prevention-658https://curecurrent.com/trials/wiredup-wearable-insoles-for-recurrent-diabetic-ulcer-prevention-659https://curecurrent.com/trials/type-2-diabetes-primary-prevention-for-at-risk-girls-660https://curecurrent.com/trials/glycemic-control-after-antenatal-corticosteroids-in-women-with-pregestational-and-gestational-diabetes-661https://curecurrent.com/trials/dosimetry-of-tc-99m-tilmanocept-662https://curecurrent.com/trials/campr-ii-rwe-trial-a-saline-hydrated-allogeneic-dual-layer-amniotic-membrane-product-or-a-synthetic-resorbable-polymeric-663https://curecurrent.com/trials/time-restricted-eating-in-patients-with-microalbuminuria-664https://curecurrent.com/trials/observational-study-to-evaluate-the-efficacy-of-sustained-qutenza-use-in-painful-diabetic-peripheral-neuropathy-665https://curecurrent.com/trials/understanding-metabolism-and-inflammation-risks-for-diabetes-in-adolescents-666https://curecurrent.com/trials/health-without-barriers-salud-sin-barreras-northern-colorado-667https://curecurrent.com/trials/facilitated-transitions-from-postpartum-to-primary-care-coordination-for-people-with-chronic-conditions-668https://curecurrent.com/trials/a-study-of-ly3938577-in-participants-with-type-2-diabetes-previously-treated-with-basal-insulin-669https://curecurrent.com/trials/a-study-to-learn-how-well-the-treatment-combination-of-finerenone-and-empagliflozin-works-and-how-safe-it-is-compared-to-670https://curecurrent.com/trials/automated-insulin-for-management-of-intrapartum-glycemia-671https://curecurrent.com/trials/glp-1-ra-on-liver-omics-in-masld-672https://curecurrent.com/trials/role-of-aging-and-individual-variation-in-exercise-training-responsiveness-673https://curecurrent.com/trials/light-metabolic-syndrome-and-alzheimer-s-disease-aim-2-674https://curecurrent.com/trials/salt-trial-study-of-ascending-levels-of-tolvaptan-in-hyponatremia-675https://curecurrent.com/trials/bead-t1d-building-the-evidence-to-address-disengagement-in-type-1-diabetes-676https://curecurrent.com/trials/miniaturized-breath-based-sensor-for-the-detection-of-hypo-and-hyperglycemia-677https://curecurrent.com/trials/reducing-metabolic-dysregulation-in-obese-latina-breast-cancer-survivors-using-physical-activity-678https://curecurrent.com/trials/emulation-of-the-rewind-cardiovascular-outcomes-trial-in-healthcare-claims-data-679https://curecurrent.com/trials/collection-of-blood-from-healthy-patients-patients-with-benign-disease-and-patients-with-cancer-680https://curecurrent.com/trials/fructose-substrate-stimulus-or-both-681https://curecurrent.com/trials/effect-of-zinc-on-glucose-homeostasis-682https://curecurrent.com/trials/clinical-decision-support-with-continuous-glucose-monitoring-data-for-managing-type-2-diabetes-683https://curecurrent.com/trials/advancing-care-coordination-between-cancer-and-primary-care-teams-for-complex-cancer-survivors-684https://curecurrent.com/trials/pilot-study-of-continuous-glucose-monitoring-for-postpartum-glucose-screening-685https://curecurrent.com/trials/implementing-the-spotlight-aq-platform-in-adolescent-young-adult-16-25-years-old-type-1-diabetics-t1d-686https://curecurrent.com/trials/study-ehr-risk-stratification-tools-687https://curecurrent.com/trials/effectiveness-of-and-implementation-strategies-for-disfrutando-688https://curecurrent.com/trials/verapamil-effect-in-cystic-fibrosis-related-dysglycemia-689https://curecurrent.com/trials/emulation-of-the-emperor-preserved-trial-using-healthcare-claims-data-690https://curecurrent.com/trials/incretin-based-therapies-for-cardiovascular-event-prevention-in-patients-with-and-without-ascvd-intercept-ascvd-691https://curecurrent.com/trials/cgm-intervention-in-teens-and-young-adults-with-type-1-diabetes-t1d-692https://curecurrent.com/trials/menu-to-meal-m2m-menu-labeling-intervention-study-693https://curecurrent.com/trials/a-research-study-to-compare-two-different-versions-of-injectable-cagrisema-in-people-with-type-2-diabetes-694https://curecurrent.com/trials/tirzepatide-vs-semaglutide-in-individuals-at-cardiovascular-risk-but-without-diabetes-695https://curecurrent.com/trials/food-is-medicine-vs-lifestyle-medicine-for-cardiovascular-kidney-metabolic-ckm-syndrome-696https://curecurrent.com/trials/injectable-semaglutide-vs-dulaglutide-in-individuals-at-cardiovascular-risk-697https://curecurrent.com/trials/vasopressin-and-pain-perception-in-the-brain-698https://curecurrent.com/trials/care-transitions-app-for-patients-with-multiple-chronic-conditions-699https://curecurrent.com/trials/community-health-workers-reduce-social-barriers-that-affect-the-health-of-patients-with-high-blood-pressure-and-diabetes-700https://curecurrent.com/trials/promoting-diabetes-education-and-management-through-peer-support-and-team-referral-701https://curecurrent.com/trials/virtual-diabetes-group-visits-across-health-systems-702https://curecurrent.com/trials/supporting-self-management-of-healthy-behaviors-in-diabetes-kidney-disease-and-hypertension-703https://curecurrent.com/trials/achieving-routine-intervention-and-screening-for-emotional-health-704https://curecurrent.com/trials/subcutaneous-pharmacokinetic-evaluation-of-monomeric-insulin-and-lyumjev-in-adults-with-type-1-diabetes-705https://curecurrent.com/trials/pregnancy-and-postpartum-cgm-in-gdm-706https://curecurrent.com/trials/diabetes-care-for-breast-cancer-patients-707https://curecurrent.com/trials/a-research-study-to-see-how-well-cagrisema-compared-to-semaglutide-cagrilintide-and-placebo-lowers-blood-sugar-and-body-708https://curecurrent.com/trials/monocytes-in-subjects-with-type-1-diabetes-and-chronic-kidney-disease-709https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-compared-with-dulaglutide-on-major-cardiovascular-events-in-participants-with-type-2-di-710https://curecurrent.com/trials/behavioral-plant-based-dietary-intervention-in-latinos-711https://curecurrent.com/trials/development-of-an-inclusive-adaptive-treatment-strategy-for-weight-loss-in-people-with-prediabetes-using-a-sequential-mu-712https://curecurrent.com/trials/glucose-mgh-genetic-links-understood-through-challenge-with-oral-semaglutide-exposure-at-mgh-713https://curecurrent.com/trials/adaptive-biobehavioral-control-abc-in-a-closed-loop-system-714https://curecurrent.com/trials/paths-up-health-behavior-self-monitoring-mobile-app-for-adolescents-715https://curecurrent.com/trials/placental-cells-for-diabetic-foot-ulcers-716https://curecurrent.com/trials/type-2-diabetes-affect-exercise-induced-improvement-in-insulin-sensitivity-717https://curecurrent.com/trials/effects-of-whole-fruit-on-blood-sugar-in-people-with-type-2-diabetes-718https://curecurrent.com/trials/adapting-and-assessing-the-feasibility-of-a-telehealth-diabetes-prevention-program-for-hispanic-adolescents-719https://curecurrent.com/trials/refinement-and-testing-of-recruitment-methodology-for-behavioral-medication-adherence-interventions-using-behavioral-sci-720https://curecurrent.com/trials/mechanisms-for-activation-of-beige-adipose-tissue-in-humans-721https://curecurrent.com/trials/antibiotic-prophylaxis-in-high-risk-arthroplasty-patients-722https://curecurrent.com/trials/effect-of-insulin-lowering-on-lipogenesis-723https://curecurrent.com/trials/platform-trial-in-stage-1-diabetes-comparing-golimumab-vs-placebo-724https://curecurrent.com/trials/miracle-t2d-montelukast-intervention-for-renal-cardiovascular-and-eye-health-in-type-2-diabetes-725https://curecurrent.com/trials/adherence-to-dyslipidemia-therapy-harnessing-evidence-from-randomized-evaluations-in-atherosclerotic-cardiovascular-dise-726https://curecurrent.com/trials/feasibility-and-effectiveness-of-a-remote-monitoring-program-for-the-treatment-of-diabetic-foot-ulcers-727https://curecurrent.com/trials/pragmatic-randomized-clinical-trial-to-limit-weight-gain-in-pregnancy-and-prevent-obesity-728https://curecurrent.com/trials/poi-for-mama-a-pilot-to-improve-maternal-microbiome-and-gestational-diabetes-risk-729https://curecurrent.com/trials/evaluation-of-basal-insulin-initialization-and-titration-in-people-with-type-2-diabetes-wearing-a-dexcom-g6-sensor-730https://curecurrent.com/trials/effects-of-exogenous-ketones-on-cognitive-function-in-older-adults-with-prediabetes-731https://curecurrent.com/trials/virtual-diabetes-care-for-adults-with-type-2-diabetes-on-medicaid-and-insulin-therapy-732https://curecurrent.com/trials/sleep-extension-or-regularity-to-reduce-diabetes-risk-733https://curecurrent.com/trials/long-covid-19-cutaneous-signatures-an-arpa-funded-research-project-734https://curecurrent.com/trials/i-can-do-this-managing-my-diabetes-735https://curecurrent.com/trials/minimed-fit-payload-wear-study-736https://curecurrent.com/trials/post-market-registry-for-the-omnipod-5-system-in-children-and-adults-with-type-1-diabetes-737https://curecurrent.com/trials/continuation-of-the-numom2b-heart-health-study-738https://curecurrent.com/trials/early-check-expanded-screening-in-newborns-739https://curecurrent.com/trials/post-market-surveillance-registry-for-the-endogenex-system-endogenex-pulse-registry-740https://curecurrent.com/trials/food-and-metabolism-study-741https://curecurrent.com/trials/trial-to-assess-chelation-therapy-in-critical-limb-ischemia-742https://curecurrent.com/trials/lowering-food-insecurity-and-improving-diabetes-with-financial-incentives-743https://curecurrent.com/trials/strategies-to-improve-well-being-and-diabetes-management-744https://curecurrent.com/trials/effect-of-montelukast-on-kidney-and-vascular-function-in-type-1-diabetes-745https://curecurrent.com/trials/safety-and-efficacy-of-adjunct-therapies-in-adults-with-type-1-diabetes-multicenter-registry-study-746https://curecurrent.com/trials/integrating-free-choice-marketplace-dietitian-coaching-culturally-tailored-messaging-to-improve-blood-pressure-747https://curecurrent.com/trials/circadian-mechanisms-glucose-and-cv-risks-in-t1d-748https://curecurrent.com/trials/family-based-treatment-for-type-1-diabetes-749https://curecurrent.com/trials/exercise-and-intranasal-insulin-in-type-2-diabetes-750https://curecurrent.com/trials/re-engineered-discharge-for-diabetes-care-transitions-751https://curecurrent.com/trials/safety-and-efficacy-of-coformulated-pembrolizumab-quavonlimab-mk-1308a-in-combination-with-lenvatinib-e7080-mk-7902-in-a-752https://curecurrent.com/trials/harvesting-health-advancing-nutrition-and-wellness-for-moms-and-babies-753https://curecurrent.com/trials/pain-and-neurological-function-improvements-with-10-khz-spinal-cord-stimulation-treatment-of-painful-diabetic-neuropathy-754https://curecurrent.com/trials/sleep-and-glycemic-control-in-type-2-diabetes-adolescents-755https://curecurrent.com/trials/optimization-of-nibs-for-diabetic-neuropathy-neuropathic-pain-756https://curecurrent.com/trials/cgm-for-management-of-type-2-diabetes-in-pregnancy-757https://curecurrent.com/trials/frexalimab-in-preservation-of-endogenous-insulin-secretion-compared-to-placebo-in-adults-adolescents-and-children-on-top-758https://curecurrent.com/trials/national-institute-of-diabetes-and-digestive-kidney-diseases-share-plus-continuous-glucose-monitoring-with-data-sharing-759https://curecurrent.com/trials/fenofibrate-for-prevention-of-dr-worsening-760https://curecurrent.com/trials/electronic-diabetes-tune-up-group-edtu-for-african-americans-761https://curecurrent.com/trials/successfully-achieving-and-maintaining-euglycemia-during-pregnancy-for-type-2-diabetes-through-technology-and-coaching-762https://curecurrent.com/trials/transdisciplinary-care-for-young-adults-with-type-1-diabetes-763https://curecurrent.com/trials/khenerfin-study-a-trial-to-evaluate-the-efficacy-and-safety-of-sonlicromanol-in-primary-mitochondrial-diseases-764https://curecurrent.com/trials/repeat-bcg-vaccinations-for-the-treatment-of-new-onset-type-1-diabetes-in-children-age-8-18-years-765https://curecurrent.com/trials/efficacy-of-kl1333-in-adult-patients-with-primary-mitochondrial-disease-766https://curecurrent.com/trials/a-study-called-fine-real-to-learn-more-about-the-use-of-the-drug-finerenone-in-a-routine-medical-care-setting-767https://curecurrent.com/trials/increasing-cgm-use-among-patients-with-t2d-768https://curecurrent.com/trials/diabetes-disparities-texting-to-extend-treatment-dd-txt-769https://curecurrent.com/trials/pdn-post-market-multicenter-prospective-global-clinical-study-770https://curecurrent.com/trials/neurologic-stem-cell-treatment-study-771https://curecurrent.com/trials/repeat-bcg-vaccinations-for-the-treatment-of-pediatric-type-1-diabetes-772https://curecurrent.com/trials/delivering-hope-helping-women-optimize-prenatal-equity-773https://curecurrent.com/trials/prise-personalized-response-and-immunologic-surveillance-of-endogenous-c-peptide-preservation-in-new-recent-and-establis-774https://curecurrent.com/trials/the-mobile-health-and-wellness-program-remote-health-study-775https://curecurrent.com/trials/effect-of-endoscopic-sleeve-gastroplasty-in-patients-with-obesity-and-mash-a-randomized-controlled-trial-776https://curecurrent.com/trials/decide-a-comparative-effectiveness-trial-of-metformin-versus-insulin-for-the-treatment-of-gestational-diabetes-777https://curecurrent.com/trials/wearable-sensory-prosthesis-to-improve-coordination-walking-and-physical-activity-778https://curecurrent.com/trials/improvement-of-hyperglycemia-diabetes-in-patients-to-improve-safety-779https://curecurrent.com/trials/circulating-biomarkers-in-the-development-of-type-1-diabetes-780https://curecurrent.com/trials/breastmilk-in-response-to-a-bout-of-exercise-781https://curecurrent.com/trials/enhanced-dpp-glb-to-promote-weight-loss-among-nonresponders-in-a-community-based-lifestyle-intervention-782https://curecurrent.com/trials/intensive-glycemic-targets-in-overweight-and-obese-women-with-gestational-diabetes-783https://curecurrent.com/trials/pilot-usability-study-to-set-up-and-use-the-feetsee-foot-monitoring-device-in-adults-with-diabetes-784https://curecurrent.com/trials/sotagliflozin-in-heart-failure-with-preserved-ejection-fraction-hfpef-patients-785https://curecurrent.com/trials/diabetes-centered-evaluation-of-revascularization-strategy-of-functional-and-imaging-combined-state-of-the-art-percutane-786https://curecurrent.com/trials/spyral-gemini-pilot-study-787https://curecurrent.com/trials/control-iq-technology-2-0-adult-and-adolescent-feasibility-study-788https://curecurrent.com/trials/resilience-based-diabetes-self-management-education-rb-dsme-for-african-americans-789https://curecurrent.com/trials/heat-and-exercise-in-aging-as-therapy-heat-790https://curecurrent.com/trials/thiamine-as-adjunctive-therapy-for-diabetic-ketoacidosis-791https://curecurrent.com/trials/multilevel-lifestyle-intervention-to-improve-physical-function-in-older-adults-with-type-2-diabetes-792https://curecurrent.com/trials/spark-cgm-implementation-793https://curecurrent.com/trials/checkpoint-inhibitor-associated-diabetes-mellitus-early-recognition-and-treatment-cert-project-a-pilot-study-794https://curecurrent.com/trials/comparative-effectiveness-of-family-dsmes-and-standard-dsmes-among-diverse-populations-795https://curecurrent.com/trials/reducing-inflammation-to-improve-vascular-and-bone-outcomes-with-low-dose-colchicine-in-ckd-796https://curecurrent.com/trials/telemedicine-for-reach-education-access-and-treatment-for-diabetes-self-management-education-and-support-797https://curecurrent.com/trials/insulin-delivery-with-self-adjusting-closed-loop-and-behavioral-glycemic-control-enhanced-by-prediction-798https://curecurrent.com/trials/reach-es-adapting-a-digital-health-tool-to-improve-diabetes-medication-adherence-among-latino-adults-799https://curecurrent.com/trials/effects-of-walking-in-greenspace-and-the-built-environment-in-adults-with-prediabetes-a-randomized-crossover-trial-800https://curecurrent.com/trials/an-observational-study-called-finerod-to-learn-more-about-the-use-of-the-treatment-finerenone-including-how-safe-it-is-a-801https://curecurrent.com/trials/personalized-dietary-management-in-type-2-diabetes-802https://curecurrent.com/trials/e3-diabetes-closing-the-gap-in-diabetes-control-803https://curecurrent.com/trials/a-phase-3-single-center-study-of-islet-transplantation-in-non-uremic-diabetic-patients-804https://curecurrent.com/trials/effect-of-urinary-alkalinization-on-urine-uric-acid-precipitation-and-crystallization-in-adults-with-type-1-diabetes-805https://curecurrent.com/trials/effect-of-the-thrive-ai-health-app-on-lifestyle-behaviors-and-quality-of-life-806https://curecurrent.com/trials/evoc-evs-in-obesity-and-cardiometabolic-disease-807https://curecurrent.com/trials/optical-coherence-tomography-angiography-in-subjects-with-retinal-vascular-disease-808https://curecurrent.com/trials/tolerability-acceptance-and-utility-of-intermittent-cgm-use-in-youth-with-prediabetes-809https://curecurrent.com/trials/evaluating-the-efficacy-neothelium-ft-in-the-treatment-of-diabetic-foot-ulcers-810https://curecurrent.com/trials/effect-of-continuing-versus-holding-metformin-during-hospitalizations-811https://curecurrent.com/trials/oasis-peer-support-for-t2dm-in-appalachia-peer-participant-812https://curecurrent.com/trials/r33-phase-delish-study-diabetes-education-to-lower-insulin-sugars-and-hunger-813https://curecurrent.com/trials/oasis-peer-support-for-t2dm-in-appalachia-peer-coaches-814https://curecurrent.com/trials/low-calorie-diet-in-isolated-impaired-fasting-glucose-815https://curecurrent.com/trials/risk-factors-costs-and-impacts-of-ed-boarding-816https://curecurrent.com/trials/dulce-digital-2-0-innovative-diabetes-self-management-in-the-digital-age-817https://curecurrent.com/trials/impact-of-menstruation-on-glycemic-response-and-exercise-in-females-with-type-1-diabetes-818https://curecurrent.com/trials/theoretically-informed-behavioral-intervention-819https://curecurrent.com/trials/allogeneic-mesenchymal-human-stem-cell-infusion-therapy-for-endothelial-dysfunction-in-diabetic-subjects-with-symptomati-820https://curecurrent.com/trials/together-overcoming-diabetes-821https://curecurrent.com/trials/mathematical-modeling-of-blood-sugar-and-hormone-responses-in-insulin-dependent-type-2-diabetes-822https://curecurrent.com/trials/scale-up-evaluation-trial-of-the-diabetes-prevention-program-to-improve-obesity-and-cardiometabolic-health-after-traumat-823https://curecurrent.com/trials/effects-of-multi-day-interruptions-in-sitting-on-type-2-diabetes-relevant-outcomes-in-children-824https://curecurrent.com/trials/modeling-ketosis-prone-diabetes-remission-via-diverse-mechanisms-of-glucotoxicity-825https://curecurrent.com/trials/phase-2-trial-of-icovamenib-in-participants-with-type-2-diabetes-mellitus-who-are-not-achieving-glycemic-targets-while-u-826https://curecurrent.com/trials/combination-adjunctive-therapy-to-address-multiple-metabolic-imbalances-in-type-1-diabetes-827https://curecurrent.com/trials/early-feasibility-study-of-adaptive-advisory-automated-aaa-control-of-type-1-diabetes-828https://curecurrent.com/trials/phentermine-topiramate-for-uric-acid-stones-829https://curecurrent.com/trials/thc-effects-on-glucose-in-type-2-diabetes-830https://curecurrent.com/trials/the-dietary-guidelines-3-diets-study-831https://curecurrent.com/trials/reducing-diabetes-distress-using-cognitive-behavioral-therapy-in-young-adults-with-type-1-diabetes-832https://curecurrent.com/trials/a-research-study-to-compare-two-types-of-insulin-a-new-insulin-insulin-icodec-and-an-available-insulin-insulin-degludec-833https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-maridebart-cafraglutide-on-insulin-sensitivity-and-cell-function-in-participants-with-834https://curecurrent.com/trials/michigan-men-s-diabetes-project-iii-mendiii-mind-and-motion-835https://curecurrent.com/trials/food-sequencing-in-food-insecurity-836https://curecurrent.com/trials/efficacy-and-safety-of-intramuscular-pda-002-in-subjects-with-diabetic-foot-ulcer-with-and-without-pad-837https://curecurrent.com/trials/diagnosis-of-gestational-diabetes-based-on-a-50-gram-glucose-challenge-838https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-once-weekly-met097-in-adults-with-obesity-or-overweight-and-t2dm-839https://curecurrent.com/trials/evaluating-the-efficacy-of-gpt-based-nutrition-and-diabetic-counseling-in-gestational-diabetes-management-a-randomized-c-840https://curecurrent.com/trials/accuracy-of-continuous-glucose-monitors-during-the-perioperative-period-in-youth-with-type-1-diabetes-841https://curecurrent.com/trials/a-research-study-to-see-how-well-the-new-weekly-medicine-icosema-which-is-a-combination-of-insulin-icodec-and-semaglutid-842https://curecurrent.com/trials/primary-care-pragmatic-real-world-experience-for-automated-insulin-delivery-843https://curecurrent.com/trials/mechanism-of-sglt2-inhibition-in-the-kidney-844https://curecurrent.com/trials/the-triabetes-armms-t2d-study-a-randomized-trial-to-compare-surgical-and-medical-treatments-for-type-2-diabetes-845https://curecurrent.com/trials/exercise-enhances-wound-healing-in-patients-with-diabetic-foot-ulcers-846https://curecurrent.com/trials/intestinal-metabolic-reprogramming-as-a-key-mechanism-of-gastric-bypass-in-humans-847https://curecurrent.com/trials/time-restricted-eating-for-type-ii-diabetes-tre-t2d-848https://curecurrent.com/trials/a-study-to-investigate-the-pharmacokinetics-of-different-formulations-and-safety-of-azd5004-in-healthy-participants-aged-849https://curecurrent.com/trials/addressing-food-access-and-physical-activity-to-improve-diabetes-prevention-outcomes-among-underserved-african-americans-850https://curecurrent.com/trials/two-way-crossover-closed-loop-study-insulin-vs-insulin-and-pramlintide-851https://curecurrent.com/trials/school-partnered-collaborative-care-space-intervention-for-children-with-type-1-diabetes-852https://curecurrent.com/trials/diabetes-prevention-in-hispanic-adults-using-constant-glucose-monitors-853https://curecurrent.com/trials/iron-reduction-for-the-treatment-of-diabetes-and-nonalcoholic-fatty-liver-disease-854https://curecurrent.com/trials/to-test-the-effectiveness-and-implementation-approach-of-a-3-month-pili-pasifika-program-lifestyle-program-with-componen-855https://curecurrent.com/trials/regulation-of-brain-glucose-metabolism-in-type-1-diabetes-856https://curecurrent.com/trials/a-study-of-retatrutide-ly3437943-in-participants-without-type-2-diabetes-who-have-obesity-or-overweight-857https://curecurrent.com/trials/anti-inflammatory-therapy-to-improve-outcomes-after-tpiat-858https://curecurrent.com/trials/village-integrated-eye-worker-trial-ii-859https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-apx3330-in-diabetic-retinopathy-860https://curecurrent.com/trials/study-of-the-scd411-prefilled-syringe-for-treating-adults-with-wet-age-related-macular-degeneration-retinal-vein-occlusi-861https://curecurrent.com/trials/effect-of-metformin-a-drug-used-to-treat-diabetes-vs-placebo-862https://curecurrent.com/trials/effects-of-lean-pork-loin-intake-on-protein-homeostasis-and-glucose-regulation-in-prediabetic-adults-863https://curecurrent.com/trials/sisters-for-heart-health-a-community-health-worker-initiative-for-improving-heart-health-in-farmworker-women-864https://curecurrent.com/trials/orthotic-treatment-of-diabetic-foot-ulcers-865https://curecurrent.com/trials/islet-transplantation-with-recipient-t-reg-cells-or-deceased-donor-vertebral-bone-marrow-therapy-866https://curecurrent.com/trials/enhancing-telemedicine-for-t2d-867https://curecurrent.com/trials/rush-food-is-medicine-veggie-rx-gusnip-produce-prescription-868https://curecurrent.com/trials/prepare-for-your-diabetes-care-869https://curecurrent.com/trials/a-research-study-to-see-how-well-new-weekly-medicine-icosema-which-is-a-combination-of-insulin-icodec-and-semaglutide-co-870https://curecurrent.com/trials/mechanisms-underlying-impaired-diabetic-wound-healing-871https://curecurrent.com/trials/a-research-study-to-compare-a-medicine-called-semaglutide-against-placebo-in-people-with-peripheral-arterial-disease-and-872https://curecurrent.com/trials/a-study-of-per-001-in-participants-with-diabetic-retinopathy-873https://curecurrent.com/trials/study-of-pda-002-in-subjects-with-peripheral-arterial-disease-and-diabetic-foot-ulcers-874https://curecurrent.com/trials/mirragen-diabetic-foot-ulcer-study-875https://curecurrent.com/trials/glucose-and-activity-tracking-for-sedentary-behavior-interventions-in-older-people-with-type-2-diabetes-track-t2d-876https://curecurrent.com/trials/ertugliflozin-cardioprotective-effects-on-epicardial-fat-877https://curecurrent.com/trials/the-effect-of-grocery-support-dose-on-food-insecurity-and-disease-control-among-covered-california-members-with-diabetes-878https://curecurrent.com/trials/continuous-glucose-monitor-for-mayo-clinic-advanced-care-at-home-patients-879https://curecurrent.com/trials/cgm-plus-gem-in-prediabetes-880https://curecurrent.com/trials/interaction-between-inorganic-nitrate-supplementation-and-metformin-in-individuals-with-prediabetes-881https://curecurrent.com/trials/glucose-monitoring-comparison-in-primary-care-882https://curecurrent.com/trials/nyuci-es-psychosocial-intervention-to-improve-health-outcomes-for-chinese-and-korean-adrd-caregivers-883https://curecurrent.com/trials/type-1-diabetes-rest-for-metabolic-health-884https://curecurrent.com/trials/impact-of-a-community-health-worker-strategy-on-produce-prescription-program-uptake-among-people-with-diabetes-885https://curecurrent.com/trials/efficacy-and-safety-of-lorundrostat-in-addition-to-sodium-glucose-cotransporter-2-inhibitors-sglt2i-in-subjects-with-hyp-886https://curecurrent.com/trials/feed-cystic-fibrosis-feed-cf-887https://curecurrent.com/trials/using-early-time-restricted-feeding-and-timed-light-therapy-to-improve-glycemic-control-in-adults-with-type-2-diabetes-888https://curecurrent.com/trials/time-restricted-eating-on-cancer-risk-889https://curecurrent.com/trials/renal-mechanism-of-sglt2-inhibition-890https://curecurrent.com/trials/effect-of-increased-physical-activity-and-stopping-evening-snacking-in-metabolic-health-in-youth-with-prediabetes-891https://curecurrent.com/trials/trial-of-semaglutide-for-diabetic-kidney-disease-in-type-1-diabetes-892https://curecurrent.com/trials/nxstan-a-culturally-tailored-intervention-to-prevent-diabetes-in-american-indian-men-893https://curecurrent.com/trials/two-way-crossover-closed-loop-mpc-vs-control-iq-894https://curecurrent.com/trials/innovative-automated-insulin-delivery-system-for-type-2-diabetes-895https://curecurrent.com/trials/fiber-mhealth-intervention-for-prediabetes-896https://curecurrent.com/trials/pre-operative-vabysmo-in-patients-with-non-clearing-vitreous-hemorrhage-secondary-to-proliferative-diabetic-retinopathy-897https://curecurrent.com/trials/study-of-subcutaneously-administered-ent-03-for-the-treatment-of-obesity-and-diabetes-898https://curecurrent.com/trials/aidanet-pediatrics-899https://curecurrent.com/trials/atrasentan-in-patients-with-proteinuric-glomerular-diseases-900https://curecurrent.com/trials/church-based-health-intervention-to-eliminate-racial-inequalities-in-cardiovascular-health-901https://curecurrent.com/trials/patient-specific-3d-printed-diabetic-insoles-to-reduce-plantar-pressure-902https://curecurrent.com/trials/a-study-of-met233-in-combination-with-met097-in-individuals-with-obesity-or-overweight-with-or-without-diabetes-903https://curecurrent.com/trials/type-1-diabetes-recurrence-in-pancreas-transplants-904https://curecurrent.com/trials/act1vate-addressing-emotional-distress-to-improve-outcomes-among-diverse-adults-with-type-1-diabetes-905https://curecurrent.com/trials/the-effect-of-3-different-models-of-mnt-on-dm-control-in-overweight-patients-with-t2dm-906https://curecurrent.com/trials/prevalence-of-nafld-and-advanced-fibrosis-in-patients-with-type-1-diabetes-907https://curecurrent.com/trials/precision-study-evaluating-the-accuracy-of-the-labpatch-continuous-glucose-monitor-908https://curecurrent.com/trials/evaluating-the-health-outcomes-of-the-joslin-why-wait-program-909https://curecurrent.com/trials/triple-therapy-in-t1dm-910https://curecurrent.com/trials/the-precision-ii-study-evaluating-the-accuracy-of-the-labpatch-glucose-sensing-system-911https://curecurrent.com/trials/transverse-tibial-transport-for-chronic-limb-threatening-ischemia-clti-912https://curecurrent.com/trials/eye-health-intervention-study-in-upper-manhattan-913https://curecurrent.com/trials/nutrition-effect-of-a-high-protein-diabetes-formula-on-body-composition-in-type-2-diabetes-patients-treated-with-increti-914https://curecurrent.com/trials/a-hybrid-effectiveness-implementation-trial-to-reduce-diabetes-distress-in-teenagers-915https://curecurrent.com/trials/effect-of-dairy-consumption-on-glycemic-control-body-weight-and-cardiovascular-risk-in-patients-with-type-2-diabetes-916https://curecurrent.com/trials/the-effects-of-glucagon-on-hepatic-metabolism-in-people-with-type-2-diabetes-after-caloric-restriction-917https://curecurrent.com/trials/amnio-maxx-in-patients-with-diabetic-foot-ulcers-unresponsive-to-standard-of-care-treatment-alone-918https://curecurrent.com/trials/derm-maxx-in-patients-with-diabetic-foot-ulcers-unresponsive-to-standard-of-care-treatment-alone-919https://curecurrent.com/trials/safety-and-feasibility-of-a-machine-learning-bolus-priming-added-to-existing-control-algorithm-920https://curecurrent.com/trials/substudy-02b-safety-and-efficacy-of-pembrolizumab-in-combination-with-investigational-agents-or-pembrolizumab-alone-in-p-921https://curecurrent.com/trials/knee-osteoarthritis-treatment-with-zilretta-vs-kenalog-in-the-context-of-type-ii-diabetes-922https://curecurrent.com/trials/evaluating-the-navajo-community-outreach-and-patient-empowerment-cope-program-923https://curecurrent.com/trials/vasq-external-support-for-arteriovenous-fistula-924https://curecurrent.com/trials/cardiometabolic-effects-of-pecan-snacking-in-prediabetes-925https://curecurrent.com/trials/a-study-of-ly3502970-in-participants-with-type-2-diabetes-926https://curecurrent.com/trials/milk-for-diabetes-prevention-927https://curecurrent.com/trials/rct-to-assess-the-efficacy-of-biophoton-therapy-to-treat-type-2-diabetes-928https://curecurrent.com/trials/culturally-tailored-program-for-food-insecure-adults-spice-d-929https://curecurrent.com/trials/a-study-to-investigate-weight-management-with-bimagrumab-ly3985863-and-tirzepatide-ly3298176-alone-or-in-combination-in-930https://curecurrent.com/trials/glycemic-control-type-ii-diabetes-parathyroidectomy-931https://curecurrent.com/trials/improving-health-communication-during-the-transition-from-pediatric-to-adult-diabetes-care-932https://curecurrent.com/trials/precision-diets-for-diabetes-prevention-933https://curecurrent.com/trials/remotely-delivered-resistance-training-for-cardiometabolic-health-among-black-women-934https://curecurrent.com/trials/culturally-tailored-diabetes-education-on-self-management-of-adult-hispanic-males-with-type-2-diabetes-mellitus-935https://curecurrent.com/trials/treat-to-improve-cardiometabolic-health-936https://curecurrent.com/trials/pathogenesis-of-kidney-disease-in-type-1-diabetes-a-modern-kidney-biopsy-cohort-the-panda-study-937https://curecurrent.com/trials/multiple-dose-study-of-mk-2828-in-participants-with-type-2-diabetes-mk-2828-003-938https://curecurrent.com/trials/a-randomized-trial-evaluating-control-iq-technology-in-adults-with-type-2-diabetes-939https://curecurrent.com/trials/plant-based-diet-for-kidney-transplant-recipients-940https://curecurrent.com/trials/phentermine-topiramate-in-adolescents-with-type-2-diabetes-and-obesity-941https://curecurrent.com/trials/combination-immunotherapy-in-colorectal-cancer-942https://curecurrent.com/trials/social-needs-screening-and-chronic-diseases-study-we-care-943https://curecurrent.com/trials/diabetes-autoimmunity-withdrawn-in-new-onset-and-in-established-patients-944https://curecurrent.com/trials/american-indian-chronic-renal-insufficiency-cohort-study-ai-cric-study-945https://curecurrent.com/trials/expansion-of-the-t1des-pilot-to-a-public-hospital-946https://curecurrent.com/trials/medbridge-guided-ncm-chw-post-discharge-support-for-high-risk-t2d-patients-947https://curecurrent.com/trials/beta-study-in-prediabetes-type-2-diabetes-948https://curecurrent.com/trials/monitoring-your-exercise-related-metrics-over-time-via-wearable-electronic-devices-949https://curecurrent.com/trials/nox1416-in-treatment-of-chronic-non-healing-diabetic-foot-ulcers-950https://curecurrent.com/trials/randomized-evaluation-of-nonhealing-diabetic-foot-ulcers-with-exclusive-wound-therapy-951https://curecurrent.com/trials/mechanisms-of-hypoglycemia-associated-autonomic-failure-952https://curecurrent.com/trials/ed-diabetes-screening-and-outpatient-care-aim-3-953https://curecurrent.com/trials/conscious-pregnancy-supporting-maternal-cardiometabolic-health-with-mindfulness-954https://curecurrent.com/trials/south-asians-with-type-2-diabetes-at-risk-for-depression-955https://curecurrent.com/trials/pactaid-app-in-adults-with-type-1-diabetes-to-help-manage-exercise-956https://curecurrent.com/trials/lactobacillus-johnsonii-supplementation-in-adults-with-t1d-957https://curecurrent.com/trials/metabolic-responses-to-bariatric-surgery-958https://curecurrent.com/trials/a1cantus-vs-placebo-959https://curecurrent.com/trials/the-metabolic-effects-of-intermittent-fasting-960https://curecurrent.com/trials/glp-1-agonist-therapy-in-cystic-fibrosis-related-glucose-intolerance-961https://curecurrent.com/trials/developing-resiliency-and-exercise-using-ai-based-messaging-962https://curecurrent.com/trials/exercise-and-time-of-day-in-type-2-diabetes-963https://curecurrent.com/trials/comparing-healthcare-visit-recording-and-open-notes-to-improve-chronic-illness-care-experience-in-older-adults-964https://curecurrent.com/trials/i-trust-implementation-of-teleophthalmology-in-rural-health-systems-study-965https://curecurrent.com/trials/comparative-effectiveness-of-tirzepatide-vs-semaglutide-in-participants-with-type-2-diabetes-and-heart-failure-with-pres-966https://curecurrent.com/trials/heterogeneity-informed-nutrition-therapy-for-gestational-diabetes-mellitus-967https://curecurrent.com/trials/pilot-of-food-is-medicine-interventions-to-reduce-cardiovascular-disease-risk-in-children-with-food-insecurity-and-diabe-968https://curecurrent.com/trials/smart-pilot-trial-of-glycemic-screening-outreach-969https://curecurrent.com/trials/once-daily-vs-twice-daily-insulin-glargine-in-pregestational-diabetes-management-970https://curecurrent.com/trials/preoperative-use-of-a-magnetically-controlled-capsule-endoscopy-in-patients-undergoing-bariatric-surgery-971https://curecurrent.com/trials/insulearn-feasibility-with-type-1-diabetes-patients-under-mdi-therapy-972https://curecurrent.com/trials/remote-pharmacy-services-plus-continuous-glucose-monitoring-in-an-underserved-population-973https://curecurrent.com/trials/diabetes-clinical-decision-support-974https://curecurrent.com/trials/thermoregulation-in-individuals-with-a-leg-amputation-975https://curecurrent.com/trials/automated-insulin-delivery-aid-for-basal-insulin-titration-in-type-2-diabetes-976https://curecurrent.com/trials/dynamically-tailored-behavioral-interventions-in-diabetes-977https://curecurrent.com/trials/monitoring-exhaled-breath-to-noninvasively-detect-glycemic-events-978https://curecurrent.com/trials/dietary-approaches-to-stop-hypertension-for-diabetes-979https://curecurrent.com/trials/identifying-oxytocin-deficiency-in-adults-with-pituitary-disease-980https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-tarcocimab-tedromer-compared-with-sham-treatment-in-participants-with-dia-981https://curecurrent.com/trials/type-1-diabetes-adolescents-for-healthier-lifestyles-study-982https://curecurrent.com/trials/famine-from-feast-linking-vitamin-c-red-blood-cell-fragility-and-diabetes-983https://curecurrent.com/trials/cleaner-air-for-lower-cardiometabolic-risk-984https://curecurrent.com/trials/technological-advances-in-glucose-management-in-older-adults-985https://curecurrent.com/trials/extended-bolus-for-meals-in-a-closed-loop-system-986https://curecurrent.com/trials/a-study-of-tirzepatide-ly3298176-compared-with-placebo-in-adults-with-type-1-diabetes-and-obesity-or-overweight-987https://curecurrent.com/trials/the-clinical-referral-to-activity-study-988https://curecurrent.com/trials/the-referral-to-hepatology-can-be-improved-through-an-electronic-medical-record-emr-based-best-practice-alert-bpa-for-an-989https://curecurrent.com/trials/glyburide-and-metformin-for-gestational-diabetes-mellitus-gdm-990https://curecurrent.com/trials/night-owl-metabolism-991https://curecurrent.com/trials/the-mount-sinai-diabetic-foot-ulcer-prospective-trial-992https://curecurrent.com/trials/diabetes-education-skills-training-and-social-needs-resolution-intervention-993https://curecurrent.com/trials/growth-hormone-resistance-of-beta-cells-a-994https://curecurrent.com/trials/light-and-the-effect-on-metabolic-syndrome-and-alzheimer-s-disease-995https://curecurrent.com/trials/community-engagement-alliance-against-disparities-996https://curecurrent.com/trials/growth-hormone-resistance-of-beta-cells-in-people-with-a-family-history-of-type-2-diabetes-997https://curecurrent.com/trials/safety-and-feasibility-of-a-self-learning-bolus-calculator-with-simplified-meal-announcement-in-adolescents-with-type-1-998https://curecurrent.com/trials/a-research-study-to-look-into-how-semaglutide-together-with-a-lower-dose-of-insulin-glargine-compares-to-a-higher-dose-o-999https://curecurrent.com/trials/feasibility-trial-using-an-inpatient-insulin-dosing-calculator-1000